ATE187083T1 - Verfahren für nadellose subkutaninjektionen - Google Patents

Verfahren für nadellose subkutaninjektionen

Info

Publication number: ATE187083T1
Authority: AT; Austria
Prior art keywords: reservoir; ampule; poppet valve; gas; pressure
Prior art date: 1992-07-24

Application number

AT93918344T

Other languages

English (en)

Inventor

Steven Fisher Peterson

Charles Neal Mckinnon Jr

Paul Edward Smith

Takaaki Nakagawa

Victor Leon Bartholomew

Original Assignee

Bioject Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-24

Filing date

1993-07-23

Publication date

1999-12-15

1993-07-23 Application filed by Bioject Inc filed Critical Bioject Inc

1999-12-15 Application granted granted Critical

1999-12-15 Publication of ATE187083T1 publication Critical patent/ATE187083T1/de

Links

238000000034 method Methods 0.000 title abstract 2
239000007929 subcutaneous injection Substances 0.000 title 1
239000003708 ampul Substances 0.000 abstract 4
238000002347 injection Methods 0.000 abstract 3
239000007924 injection Substances 0.000 abstract 3
239000003999 initiator Substances 0.000 abstract 2
238000005336 cracking Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M2005/31516—Piston or piston-rod constructions, e.g. connection of piston with piston-rod reducing dead-space in the syringe barrel after delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum

Landscapes

Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

AT93918344T 1992-07-24 1993-07-23 Verfahren für nadellose subkutaninjektionen ATE187083T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/920,106 US5383851A (en)	1992-07-24	1992-07-24	Needleless hypodermic injection device

Publications (1)

Publication Number	Publication Date
ATE187083T1 true ATE187083T1 (de)	1999-12-15

Family

ID=25443171

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93918344T ATE187083T1 (de)	1992-07-24	1993-07-23	Verfahren für nadellose subkutaninjektionen

Country Status (8)

Country	Link
US (3)	US5383851A (de)
EP (1)	EP0651663B1 (de)
JP (2)	JP3633615B2 (de)
AT (1)	ATE187083T1 (de)
AU (1)	AU676490B2 (de)
CA (1)	CA2140772C (de)
DE (1)	DE69327165T2 (de)
WO (1)	WO1994002188A1 (de)

Families Citing this family (1184)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2689017B1 (fr) *	1992-03-31	1994-05-27	Mtc Medical	Appareil d'injection medicale ou veterinaire.
US5383851A (en) *	1992-07-24	1995-01-24	Bioject Inc.	Needleless hypodermic injection device
US5405333A (en) *	1992-12-28	1995-04-11	Richmond; Frank M.	Liquid medicament bag with needleless connector fitting using boat assembly
US6206860B1 (en)	1993-07-28	2001-03-27	Frank M. Richmond	Spikeless connection and drip chamber with valve
US5540657A (en) *	1994-07-15	1996-07-30	Collagen Corporation	Delivery device for injectable materials
DE19519279A1 (de) *	1994-12-07	1996-08-22	Wolfgang Dr Med Wagner	Verfahren und Einrichtung zur Saug-Druckinjektion
US5599302A (en)	1995-01-09	1997-02-04	Medi-Ject Corporation	Medical injection system and method, gas spring thereof and launching device using gas spring
DE29507987U1 (de) *	1995-05-15	1996-09-19	Ferton Holding, Delemont	Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
US5893397A (en) *	1996-01-12	1999-04-13	Bioject Inc.	Medication vial/syringe liquid-transfer apparatus
US5800388A (en)	1996-02-29	1998-09-01	Medi-Ject Corporation	Plunger/ram assembly adapted for a fluid injector
US5697917A (en)	1996-02-29	1997-12-16	Medi-Ject Corporation	Nozzle assembly with adjustable plunger travel gap
US5722953A (en)	1996-02-29	1998-03-03	Medi-Ject Corporation	Nozzle assembly for injection device
US5643211A (en)	1996-02-29	1997-07-01	Medi-Ject Corporation	Nozzle assembly having a frangible plunger
US5921967A (en)	1996-02-29	1999-07-13	Medi-Ject Corporation	Plunger for nozzle assembly
US5865795A (en)	1996-02-29	1999-02-02	Medi-Ject Corporation	Safety mechanism for injection devices
US5785688A (en) *	1996-05-07	1998-07-28	Ceramatec, Inc.	Fluid delivery apparatus and method
KR100376646B1 (ko)	1996-07-01	2003-03-15	파마시아 에이비	전달 장치 및 이것의 작동 방법
US6458574B1 (en)	1996-09-12	2002-10-01	Transkaryotic Therapies, Inc.	Treatment of a α-galactosidase a deficiency
US6106502A (en) *	1996-12-18	2000-08-22	Richmond; Frank M.	IV sets with needleless fittings and valves
US5875976A (en)	1996-12-24	1999-03-02	Medi-Ject Corporation	Locking mechanism for nozzle assembly
US5993412A (en) *	1997-05-19	1999-11-30	Bioject, Inc.	Injection apparatus
US5911703A (en) *	1997-05-22	1999-06-15	Avant Drug Delivery Systems, Inc.	Two-stage fluid medicament jet injector
US5947928A (en) *	1997-06-19	1999-09-07	Mile Creek Capital, Llc	Drug delivery system
USD399951S (en)	1997-06-30	1998-10-20	Bioject, Inc.	Injection apparatus
US5964735A (en) *	1997-07-01	1999-10-12	Medisys Technologies, Inc.	Fine needle aspiration safety syringe
EP0888790A1 (de) *	1997-07-04	1999-01-07	PowderJect Research Limited	Vorrichtung zur Abgabe von Medikamententeilchen
US6569127B1 (en) *	1997-07-18	2003-05-27	Liebel-Flarsheim Company	Adapter and syringe for front-loading medical fluid injector
US6171276B1 (en)	1997-08-06	2001-01-09	Pharmacia & Upjohn Ab	Automated delivery device and method for its operation
US6071272A (en) *	1997-10-28	2000-06-06	Hoffman; Alan S.	Method for treating erectile dysfunctionality
US6610042B2 (en)	1997-12-05	2003-08-26	Felton Medical, Inc.	Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
US6541606B2 (en) *	1997-12-31	2003-04-01	Altus Biologics Inc.	Stabilized protein crystals formulations containing them and methods of making them
US5993418A (en) *	1998-02-24	1999-11-30	Medisys Technologies, Inc.	Safety syringe
US20020147143A1 (en)	1998-03-18	2002-10-10	Corixa Corporation	Compositions and methods for the therapy and diagnosis of lung cancer
AU3489499A (en)	1998-04-14	1999-11-01	Merck & Co., Inc.	Needleless administration of polynucleotide formulations
JP4294868B2 (ja)	1998-07-27	2009-07-15	アンテアリーズファーマインコーポレイテッド	医療用注射器組立体用の注射補助プローブ
WO2000006227A1 (en) *	1998-07-27	2000-02-10	Medi-Ject Corporation	Loading mechanism for medical injector assembly
GB9818110D0 (en) *	1998-08-19	1998-10-14	Weston Medical Ltd	Needleless injectors and other devices
US6532386B2 (en)	1998-08-31	2003-03-11	Johnson & Johnson Consumer Companies, Inc.	Electrotransort device comprising blades
US20030235557A1 (en)	1998-09-30	2003-12-25	Corixa Corporation	Compositions and methods for WT1 specific immunotherapy
US6783509B1 (en)	1998-11-18	2004-08-31	Bioject Inc.	Single-use needle-less hypodermic jet injection apparatus and method
US6132395A (en) *	1998-12-08	2000-10-17	Bioject, Inc.	Needleless syringe with prefilled cartridge
US6383168B1 (en)	1998-12-08	2002-05-07	Bioject Medical Technologies Inc.	Needleless syringe with prefilled cartridge
US6406455B1 (en) *	1998-12-18	2002-06-18	Biovalve Technologies, Inc.	Injection devices
DE19859137C1 (de) *	1998-12-21	2000-05-18	Ferton Holding Sa	Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
US6328714B1 (en) *	1999-01-29	2001-12-11	Powderject Research Limited	Particle delivery device
US6849060B1 (en)	1999-01-29	2005-02-01	Powderject Research Limited	Particle delivery device
JP4180244B2 (ja)	1999-04-16	2008-11-12	ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド	内部センサを有する電気的な移動による送出装置系
US7060048B1 (en) *	1999-04-16	2006-06-13	Powerject Research Limited	Needleless syringe
WO2000064514A1 (en) *	1999-04-22	2000-11-02	Gilbert Garitano	Needleless permanent makeup and tattoo device
US6689103B1 (en)	1999-05-07	2004-02-10	Scimed Life System, Inc.	Injection array apparatus and method
US6319230B1 (en)	1999-05-07	2001-11-20	Scimed Life Systems, Inc.	Lateral needle injection apparatus and method
US7192713B1 (en)	1999-05-18	2007-03-20	President And Fellows Of Harvard College	Stabilized compounds having secondary structure motifs
US7147633B2 (en) *	1999-06-02	2006-12-12	Boston Scientific Scimed, Inc.	Method and apparatus for treatment of atrial fibrillation
WO2000072908A1 (en) *	1999-06-02	2000-12-07	Microheart, Inc.	Devices and methods for delivering a drug
AU6076200A (en)	1999-07-08	2001-01-30	Johnson & Johnson Consumer Companies, Inc.	Exothermic bandage
US6890553B1 (en)	1999-07-08	2005-05-10	Johnson & Johnson Consumer Companies, Inc.	Exothermic topical delivery device
US20050027239A1 (en) *	1999-08-20	2005-02-03	Stout Richard R.	Intradermal injection system for injecting DNA-based injectables into humans
US6319224B1 (en) *	1999-08-20	2001-11-20	Bioject Medical Technologies Inc.	Intradermal injection system for injecting DNA-based injectables into humans
AU7064700A (en) *	1999-08-20	2001-03-19	Bioject, Inc.	Intramuscular injection system for injecting dna-based injectables into humans
EP1212422B1 (de)	1999-08-24	2007-02-21	Medarex, Inc.	Humane antikörper gegen ctla-4 und deren verwendungen
US7113821B1 (en)	1999-08-25	2006-09-26	Johnson & Johnson Consumer Companies, Inc.	Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) *	1999-08-25	2006-11-07	Johnson & Johnson Consumer Companies, Inc.	Tissue electroperforation for enhanced drug delivery and diagnostic sampling
ATE285806T1 (de)	1999-10-11	2005-01-15	Felton International Inc	Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7074210B2 (en) *	1999-10-11	2006-07-11	Felton International, Inc.	Universal protector cap with auto-disable features for needle-free injectors
US6776776B2 (en) *	1999-10-14	2004-08-17	Becton, Dickinson And Company	Prefillable intradermal delivery device
US20020193740A1 (en)	1999-10-14	2002-12-19	Alchas Paul G.	Method of intradermally injecting substances
US6494865B1 (en)	1999-10-14	2002-12-17	Becton Dickinson And Company	Intradermal delivery device including a needle assembly
US6569143B2 (en)	1999-10-14	2003-05-27	Becton, Dickinson And Company	Method of intradermally injecting substances
US6843781B2 (en) *	1999-10-14	2005-01-18	Becton, Dickinson And Company	Intradermal needle
US6569123B2 (en)	1999-10-14	2003-05-27	Becton, Dickinson And Company	Prefillable intradermal injector
CA2392598C (en) *	1999-11-23	2010-06-08	Needleless Ventures, Inc.	Injector assembly with driving means and locking means
US7887506B1 (en)	1999-11-23	2011-02-15	Pulse Needlefree Systems, Inc.	Safety mechanism to prevent accidental patient injection and methods of same
US7029457B2 (en) *	1999-11-23	2006-04-18	Felton International, Inc.	Jet injector with hand piece
US6770054B1 (en)	1999-11-23	2004-08-03	Felton International, Inc.	Injector assembly with driving means and locking means
US6344027B1 (en)	1999-12-08	2002-02-05	Scimed Life Systems, Inc.	Needle-less injection apparatus and method
US6613026B1 (en) *	1999-12-08	2003-09-02	Scimed Life Systems, Inc.	Lateral needle-less injection apparatus and method
CA2396569C (en) *	2000-01-07	2010-03-23	Biovalve Technologies, Inc.	Injection device
IL151097A0 (en)	2000-02-23	2003-04-10	Smithkline Beecham Biolog	Tumour-specific animal proteins
FR2805749B1 (fr) *	2000-03-01	2002-05-17	Poudres & Explosifs Ste Nale	Seringue sans aiguille a deux niveaux de vitesse d'injection
US7137968B1 (en) *	2000-03-13	2006-11-21	Nucryst Pharmaceuticals Corp.	Transcutaneous medical device dressings and method of use
WO2001070309A1 (en) *	2000-03-23	2001-09-27	Antares Pharma, Inc.	Single use disposable jet injector
US6719987B2 (en)	2000-04-17	2004-04-13	Nucryst Pharmaceuticals Corp.	Antimicrobial bioabsorbable materials
FR2807946B1 (fr)	2000-04-19	2002-06-07	Poudres & Explosifs Ste Nale	Seringue sans aiguille fonctionnant avec un chargement pyrotechnique bicomposition
US6716190B1 (en) *	2000-04-19	2004-04-06	Scimed Life Systems, Inc.	Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body
US7404815B2 (en) *	2000-05-01	2008-07-29	Lifescan, Inc.	Tissue ablation by shear force for sampling biological fluids and delivering active agents
US6689101B2 (en) *	2000-05-22	2004-02-10	Pharmacia Ab	Medical arrangement
US6645169B1 (en) *	2000-06-08	2003-11-11	Avant Drug Delivery Systems, Inc.	Air-in-tip jet injector
US6406456B1 (en)	2000-06-08	2002-06-18	Avant Drug Delivery Systems, Inc.	Jet injector
DE10029325A1 (de)	2000-06-20	2002-01-03	Peter Lell	Nadellose Injektionsvorrichtung mit pyrotechnischem Antrieb
AR029540A1 (es)	2000-06-28	2003-07-02	Corixa Corp	COMPOSICIONES Y METODOS PARA EL DIAGNoSTICO Y LA TERAPIA DE CA NCER DE PULMoN
US6989157B2 (en) *	2000-07-27	2006-01-24	Nucryst Pharmaceuticals Corp.	Dry powders of metal-containing compounds
US20030206966A1 (en) *	2000-07-27	2003-11-06	Burrell Robert E.	Methods of inducing apoptosis and modulating metalloproteinases
US20040191329A1 (en) *	2000-07-27	2004-09-30	Burrell Robert E.	Compositions and methods of metal-containing materials
US7001617B2 (en)	2001-04-23	2006-02-21	Nueryst Pharmaceuticals Corp.	Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US20030180379A1 (en) *	2000-07-27	2003-09-25	Burrell Robert E.	Solutions and aerosols of metal-containing compounds
US7255881B2 (en) *	2000-07-27	2007-08-14	Nucryst Pharmaceuticals Corp.	Metal-containing materials
AU2001278322B2 (en)	2000-07-27	2005-12-22	Smith & Nephew (Overseas) Limited	Treatment of hyperproliferative skin disorders and diseases
US7008647B2 (en) *	2001-04-23	2006-03-07	Nucryst Pharmaceuticals Corp.	Treatment of acne
US7427416B2 (en) *	2000-07-27	2008-09-23	Nucryst Pharmaceuticals Corp.	Methods of treating conditions using metal-containing materials
US20030185901A1 (en)	2000-07-27	2003-10-02	Burrell Robert E.	Methods of treating conditions with a metal-containing material
GB0022742D0 (en)	2000-09-15	2000-11-01	Smithkline Beecham Biolog	Vaccine
CA2324045A1 (fr) *	2000-10-20	2002-04-20	Universite De Sherbrooke	Seringue sans aiguille pour l'injection sous-cutanee de poudres medicamenteuses
FR2815544B1 (fr)	2000-10-23	2003-02-14	Poudres & Explosifs Ste Nale	Seringue sans aiguille securisee a architecture compacte
US6652483B2 (en) *	2000-11-07	2003-11-25	Avant Drug Delivery Systems, Inc.	Needleless jet injector system with separate drug reservoir
US6626863B1 (en)	2000-11-22	2003-09-30	Nusaf, L.L.C.	Safety syringe
US7931614B2 (en) *	2000-11-30	2011-04-26	Valeritas, Inc.	Injection systems
GB0100756D0 (en)	2001-01-11	2001-02-21	Powderject Res Ltd	Needleless syringe
EP1351730B1 (de) *	2001-01-18	2006-06-28	Medrad, Inc.	Spritzenanschlussflächen und adaptern für verwendung mit medizinische injektoren
US6758837B2 (en)	2001-02-08	2004-07-06	Pharmacia Ab	Liquid delivery device and method of use thereof
EP2281573A3 (de)	2001-02-23	2011-12-07	GlaxoSmithKline Biologicals s.a.	Influenza Vakzinzusammensetzungen zur intradermaler Verabreichung
US6471669B2 (en) *	2001-03-05	2002-10-29	Bioject Medical Technologies Inc.	Disposable needle-free injection apparatus and method
US6645170B2 (en) *	2001-03-05	2003-11-11	Bioject Medical Technologies, Inc.	Simplified disposable needle-free injection apparatus and method
US20020172615A1 (en) *	2001-03-08	2002-11-21	Archie Woodworth	Apparatus for and method of manufacturing a prefilled sterile container
US20020139088A1 (en)	2001-03-08	2002-10-03	Archie Woodworth	Polymeric syringe body and stopper
CA2440983A1 (en)	2001-03-14	2002-09-26	Penjet Corporation	System and method for removing dissolved gas from a solution
ZA200200808B (en)	2001-03-22	2002-08-12	Roche Diagnostics Gmbh	Needleless hypodermic injection system, application device and medication cartridge therefor.
US7795218B2 (en)	2001-04-12	2010-09-14	Bioaxone Therapeutique Inc.	ADP-ribosyl transferase fusion variant proteins
GB0109297D0 (en)	2001-04-12	2001-05-30	Glaxosmithkline Biolog Sa	Vaccine
US20050192530A1 (en) *	2001-04-13	2005-09-01	Penjet Corporation	Method and apparatus for needle-less injection with a degassed fluid
US6613010B2 (en) *	2001-04-13	2003-09-02	Penjet Corporation	Modular gas-pressured needle-less injector
JP2004529929A (ja) *	2001-04-23	2004-09-30	ニュクリストファーマシューティカルズコーポレーション	アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用
US6755220B2 (en)	2001-04-27	2004-06-29	Penjet Corporation	Method and apparatus for filling or refilling a needle-less injector
JP2005504513A (ja)	2001-05-09	2005-02-17	コリクサコーポレイション	前立腺癌の治療及び診断のための組成物及び方法
MY134424A (en)	2001-05-30	2007-12-31	Saechsisches Serumwerk	Stable influenza virus preparations with low or no amount of thiomersal
US20100221284A1 (en)	2001-05-30	2010-09-02	Saech-Sisches Serumwerk Dresden	Novel vaccine composition
US6648850B2 (en) *	2001-06-08	2003-11-18	Bioject, Inc.	Durable needle-less jet injector apparatus and method
CN1253220C (zh) *	2001-06-29	2006-04-26	贝克顿迪肯森公司	通过微管在真皮内输入疫苗和基因治疗剂
US20060018877A1 (en) *	2001-06-29	2006-01-26	Mikszta John A	Intradermal delivery of vacccines and therapeutic agents
US7544188B2 (en) *	2001-07-19	2009-06-09	Intelliject, Inc.	Medical injector
US7767872B2 (en) *	2001-09-06	2010-08-03	Mpg Biotechnologies, Llc	Thimerosal removal device
US8440791B2 (en) *	2001-09-06	2013-05-14	Mgp Biotechnologies, Llc	Thimerosal removal device
US6669664B2 (en)	2001-09-07	2003-12-30	Avant Drug Delivery Systems, Inc.	Vacuum control cycle for jet injector
MXPA04002631A (es) *	2001-09-20	2004-07-08	Glaxo Group Ltd	Vacunas de adn optimizadas por codon gag-vih.
US6824526B2 (en)	2001-10-22	2004-11-30	Penjet Corporation	Engine and diffuser for use with a needle-less injector
GB0125506D0 (en)	2001-10-24	2001-12-12	Weston Medical Ltd	Needle free injection method and apparatus
DE60236949D1 (de) *	2001-11-09	2010-08-19	Alza Corp	Pneumatisch angetriebener autoinjektor
US6607510B2 (en)	2001-11-09	2003-08-19	Bioject Medical Technologies Inc.	Disposable needle-free injection apparatus and method
CA2465901C (en) *	2001-11-09	2010-10-26	Pedro De La Serna	Collapsible syringe cartridge
TWI222370B (en) *	2001-12-14	2004-10-21	Roche Diagnostics Gmbh	Needleless hypodermic injection device
DK2224012T3 (da)	2001-12-17	2013-05-13	Corixa Corp	Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme
WO2003074102A2 (en) *	2002-03-04	2003-09-12	Nano Pass Technologies Ltd.	Devices and methods for transporting fluid across a biological barrier
US6912417B1 (en)	2002-04-05	2005-06-28	Ichor Medical Systmes, Inc.	Method and apparatus for delivery of therapeutic agents
MXPA04009959A (es)	2002-04-12	2004-12-13	Schering Corp	Ligandos del receptor acoplado a la proteina g y metodos.
DK1503788T3 (da)	2002-04-25	2011-10-17	Shire Human Genetic Therapies	Behandling af alpha-galactosidase A-deficiens
EP1506286B1 (de)	2002-05-24	2014-03-19	Merck Sharp & Dohme Corp.	Neutralisierung eines menschlichen anti-igfr-antikörpers
US6676630B2 (en)	2002-06-04	2004-01-13	Bioject Medical Technologies, Inc.	Needle-free injection system
US7238167B2 (en) *	2002-06-04	2007-07-03	Bioject Inc.	Needle-free injection system
US7156823B2 (en) *	2002-06-04	2007-01-02	Bioject Inc.	High workload needle-free injection system
US20040132058A1 (en)	2002-07-19	2004-07-08	Schering Corporation	NPC1L1 (NPC3) and methods of use thereof
US6883222B2 (en) *	2002-10-16	2005-04-26	Bioject Inc.	Drug cartridge assembly and method of manufacture
BRPI0315295C1 (pt)	2002-10-17	2021-05-25	Genmab As	anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão
US20040110738A1 (en) *	2002-10-22	2004-06-10	Gillis Scott H.	Prophylactic treatment methods
US7018356B2 (en)	2002-10-31	2006-03-28	Wise Roger R	Method and apparatus for adjusting the contents of a needle-less injector
DE10254601A1 (de)	2002-11-22	2004-06-03	Ganymed Pharmaceuticals Ag	Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2003275895B2 (en)	2002-11-25	2009-02-05	Tecpharma Licensing Ag	Auto-injector comprising a resettable releasing safety device
CN101863930A (zh)	2003-01-06	2010-10-20	科里克萨有限公司	一些氨烷基氨基葡糖苷磷酸酯化合物和它们的用途
US7960522B2 (en)	2003-01-06	2011-06-14	Corixa Corporation	Certain aminoalkyl glucosaminide phosphate compounds and their use
DK1587907T3 (da)	2003-01-07	2011-04-04	Dyax Corp	Kunitz-domænebibliotek
EP2857036B1 (de)	2003-01-31	2016-12-21	Mount Sinai School of Medicine of New York University	Kombinationstherapie zur behandlung von proteinmangelstörungen
US6935384B2 (en) *	2003-02-19	2005-08-30	Bioject Inc.	Needle-free injection system
FR2852517B1 (fr) *	2003-03-21	2005-11-11		Dispositif d'injection sans aiguille a cartouche pyrotechnique et procede d'assemblage d'un tel dispositif
EP1620147A4 (de) *	2003-04-21	2008-06-11	Corium Internat Inc	Gerät und verfahren für die repetitive mikrostrahl-arzneimittelabgabe
US20060184101A1 (en) *	2003-04-21	2006-08-17	Ravi Srinivasan	Microjet devices and methods for drug delivery
JP2007525458A (ja)	2003-04-23	2007-09-06	メダレックスインコーポレイテッド	インターフェロンα受容体−１（ＩＦＮＡＲ−１）に対するヒト化抗体
WO2004110533A1 (ja) *	2003-05-09	2004-12-23	Anges Mg, Inc.	薬剤が収容された針無注射器
WO2005026375A2 (en)	2003-05-22	2005-03-24	Fraunhofer Usa, Inc.	Recombinant carrier molecule for expression, delivery and purification of target polypeptides
WO2005034949A1 (en) *	2003-09-09	2005-04-21	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
IL157981A (en)	2003-09-17	2014-01-30	Elcam Medical Agricultural Cooperative Ass Ltd	Auto injector
GB0325836D0 (en) *	2003-11-05	2003-12-10	Celltech R&D Ltd	Biological products
EP1685865A4 (de) *	2003-11-21	2009-12-30	Zhongshan Botai Pharmaceutic I	Spritze zum vormischen eines pulverförmigen medikaments
HUE026260T2 (en)	2003-11-21	2016-06-28	Ucb Biopharma Sprl	A method for treating multiple sclerosis by inhibiting IL-17 activity
PL1691837T3 (pl)	2003-12-10	2012-11-30	Squibb & Sons Llc	IP-10 przeciwciała i ich zastosowanie
KR101225299B1 (ko)	2003-12-10	2013-01-24	메다렉스, 인코포레이티드	인터페론 알파 항체 및 그의 용도
EP1713900A4 (de) *	2004-01-27	2009-06-17	Compugen Ltd	Verfahren und systeme zur kommentierung biomolekularer sequenzen
HUE025052T2 (en)	2004-03-08	2016-01-28	Ichor Medical Systems Inc	A sharpened device for electrically mediated delivery of medical substances
IL160891A0 (en)	2004-03-16	2004-08-31		Auto-mix needle
DE102004024617A1 (de)	2004-05-18	2005-12-29	Ganymed Pharmaceuticals Ag	Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1753458A4 (de) *	2004-05-19	2009-07-22	Wyeth Corp	Modulation der immunglobulinproduktion und atopische erkrankungen
US7717874B2 (en) *	2004-05-28	2010-05-18	Bioject, Inc.	Needle-free injection system
US7662381B2 (en)	2004-06-21	2010-02-16	Medarex, Inc.	Interferon alpha receptor 1 antibodies and their uses
CA2575791A1 (en)	2004-08-03	2006-02-16	Dyax Corp.	Hk1-binding proteins
GB0417852D0 (en)	2004-08-11	2004-09-15	Biotica Tech Ltd	Production of polyketides and other natural products
US20060040895A1 (en) *	2004-08-19	2006-02-23	Kipling Thacker	Aesthetic use of hyaluronan
CA2478458A1 (en) *	2004-08-20	2006-02-20	Michael Panzara	Treatment of pediatric multiple sclerosis
NZ553776A (en)	2004-09-22	2010-05-28	Glaxosmithkline Biolog Sa	Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
WO2007001448A2 (en) *	2004-11-04	2007-01-04	Massachusetts Institute Of Technology	Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
CA2585719A1 (en)	2004-11-08	2006-05-18	Schering Corporation	Tumor association of mdl-1 and methods
CA2629751A1 (en)	2004-11-12	2006-05-18	The University Of British Columbia	Antimicrobial peptides
CA2587597A1 (en)	2004-11-19	2006-05-26	Biogen Idec Ma Inc.	Treatment for multiple sclerosis
US10737028B2 (en)	2004-11-22	2020-08-11	Kaleo, Inc.	Devices, systems and methods for medicament delivery
US11590286B2 (en)	2004-11-22	2023-02-28	Kaleo, Inc.	Devices, systems and methods for medicament delivery
US7947017B2 (en) *	2004-11-22	2011-05-24	Intelliject, Inc.	Devices, systems and methods for medicament delivery
US7648483B2 (en)	2004-11-22	2010-01-19	Intelliject, Inc.	Devices, systems and methods for medicament delivery
EP1814611A4 (de)	2004-11-22	2010-06-02	Intelliject Inc	Vorrichtungen, systeme und verfahren zur abgabe eines medikaments
US7648482B2 (en) *	2004-11-22	2010-01-19	Intelliject, Inc.	Devices, systems, and methods for medicament delivery
BRPI0515759B8 (pt) *	2004-12-01	2021-06-22	Acushot Inc	dispositivo de injeção sem agulha e kit para utilização do mesmo
NZ581497A (en) *	2004-12-03	2012-07-27	Biogen Idec Inc	Delaying or preventing onset of multiple sclerosis by vla-4 ginding antibody
PT1828249E (pt)	2004-12-03	2011-02-25	Schering Corp	Biomarcadores para a pré-selecção de pacientes para terapêutica anti-igf1r
US7351226B1 (en) *	2004-12-07	2008-04-01	Glenn Herskowitz	Medical infusion pump
JP2008527996A (ja) *	2005-01-25	2008-07-31	スカイ、ジェネティクス、インク	癌細胞のアポトーシスのための核酸
US20060183893A1 (en) *	2005-01-25	2006-08-17	North Don A	Nucleic acids for apoptosis of cancer cells
US8361026B2 (en)	2005-02-01	2013-01-29	Intelliject, Inc.	Apparatus and methods for self-administration of vaccines and other medicaments
GB2451769B (en)	2005-02-01	2009-12-09	Intelliject Llc	Devices, systems, and methods for medicament delivery
US9022980B2 (en)	2005-02-01	2015-05-05	Kaleo, Inc.	Medical injector simulation device
US8231573B2 (en)	2005-02-01	2012-07-31	Intelliject, Inc.	Medicament delivery device having an electronic circuit system
US7731686B2 (en)	2005-02-01	2010-06-08	Intelliject, Inc.	Devices, systems and methods for medicament delivery
US8206360B2 (en)	2005-02-01	2012-06-26	Intelliject, Inc.	Devices, systems and methods for medicament delivery
WO2006089095A2 (en)	2005-02-17	2006-08-24	Biogen Idec Ma Inc.	Treating neurological disorders
ES2498794T3 (es)	2005-02-18	2014-09-25	Medarex, L.L.C.	Anticuerpos monoclonales contra CD30 que carecen de restos fucosilo
US20100061994A1 (en) *	2005-03-11	2010-03-11	Rose Mary Sheridan	Medical uses of 39-desmethoxyrapamycin and analogues thereof
GB0504994D0 (en) *	2005-03-11	2005-04-20	Biotica Tech Ltd	Novel compounds
JP5225069B2 (ja)	2005-03-23	2013-07-03	ゲンマブエー／エス	多発性骨髄腫の治療のためのｃｄ３８に対する抗体
AR054020A1 (es)	2005-03-23	2007-05-30	Glaxosmithkline Biolog Sa	Nuevo uso
EP1863519B1 (de)	2005-03-31	2013-09-25	The General Hospital Corporation	Modulation von hgf/hgfr-aktivität zur behandlung von lymphödem
BRPI0610644B8 (pt)	2005-04-04	2021-05-25	Univ Florida	composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
DK2439273T3 (da)	2005-05-09	2019-06-03	Ono Pharmaceutical Co	Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
EP3782655A1 (de)	2005-05-17	2021-02-24	Amicus Therapeutics, Inc.	Verfahren zur behandlung der pompe-krankheit unter verwendung von 1-deoxynojirimycin und derivaten
MEP35408A (en)	2005-05-27	2011-02-10	Biogen Idec Inc	Tweak binding antibodies
US20060271014A1 (en) *	2005-05-31	2006-11-30	Mallinckrodt Inc.	Heat retention device for a syringe and methods of use
US20070118093A1 (en) *	2005-06-20	2007-05-24	Von Muhlen Marcio G	High-speed jet devices for drug delivery
PT1907424E (pt)	2005-07-01	2015-10-09	Squibb & Sons Llc	Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
US20100119525A1 (en) *	2005-08-01	2010-05-13	Mount Sinai Schoool Of Medicine Of New York University	Method for extending longevity using npc1l1 antagonists
JP2009502207A (ja) *	2005-08-03	2009-01-29	フラウンホーファーユーエスエー，インコーポレイテッド	イムノグロブリンの産生のための組成物および方法
US8591457B2 (en) *	2005-08-10	2013-11-26	Alza Corporation	Method for making a needle-free jet injection drug delivery device
EP1762575A1 (de) *	2005-09-12	2007-03-14	Ganymed Pharmaceuticals AG	Identifizierung Tumor-assoziierter Antigene für Diagnoseund Therapie
NZ566395A (en)	2005-09-26	2012-03-30	Medarex Inc	Human monoclonal antibodies to CD70
WO2007045477A2 (en)	2005-10-21	2007-04-26	Novartis Ag	Human antibodies against il-13 and therapeutic uses
US20070099246A1 (en) *	2005-11-03	2007-05-03	Sandy John D	Antibodies, assays and kits to quantitate cartilage destruction
CN103071209A (zh) *	2005-11-17	2013-05-01	周吉尼克斯股份有限公司	用无针注射递送粘稠制剂
EP1790664A1 (de)	2005-11-24	2007-05-30	Ganymed Pharmaceuticals AG	Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US7695449B2 (en) *	2005-12-05	2010-04-13	Xinming Wang	Automatic syringe
US8383118B2 (en)	2005-12-08	2013-02-26	Medarex, Inc.	Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
WO2007070682A2 (en) *	2005-12-15	2007-06-21	Massachusetts Institute Of Technology	System for screening particles
KR101515078B1 (ko)	2005-12-22	2015-04-24	글락소스미스클라인 바이오로지칼즈 에스.에이.	백신
GB0607088D0 (en)	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
EP2441846A3 (de)	2006-01-09	2012-07-25	The Regents Of the University of California	Immunstimulierende Kombinationen aus TNFRSF, TLR, NLR, RHR, purinergischem Rezeptor, und Zytokin-Rezeptor-Antagonisten für Impfstoffe und die Tumorimmuntherapie
US20070166774A1 (en) *	2006-01-17	2007-07-19	Groman Ernest V	Functional immunoassay
HRP20120994T1 (hr)	2006-02-07	2012-12-31	Shire Human Genetic Therapies, Inc.	Stabilizirana smjesa glukocerebrozidaze
CN104162200B (zh) *	2006-02-09	2018-03-27	德卡产品有限公司	外围系统
KR20080106434A (ko) *	2006-02-13	2008-12-05	프라운호퍼 유에스에이, 인코포레이티드	Ｈｐｖ 항원, 백신 조성물 및 관련된 방법
US8277816B2 (en) *	2006-02-13	2012-10-02	Fraunhofer Usa, Inc.	Bacillus anthracis antigens, vaccine compositions, and related methods
BRPI0707733B1 (pt) *	2006-02-13	2019-12-31	Ibio, Inc.	antígeno isolado, composição de vacina, uso da referida composição e método para produção de uma proteína de antígeno
AU2007218014A1 (en) *	2006-02-17	2007-08-30	Alan L. Buchman	Catheter cleaning devices
WO2007106415A2 (en) *	2006-03-10	2007-09-20	Massachusetts Institute Of Technology	Triggered self-assembly conjugates and nanosystems
WO2007111806A2 (en)	2006-03-23	2007-10-04	Massachusetts Eye And Ear Infirmary	Cyclopentane heptanoic acid compounds for reducing body fat
WO2007121054A2 (en) *	2006-03-27	2007-10-25	Sky Genetics, Inc.	Nucleic acids for apoptosis of cancer cells
EP2476433A1 (de)	2006-03-30	2012-07-18	GlaxoSmithKline Biologicals S.A.	Immunogene Zusammensetzung
CA2648099C (en) *	2006-03-31	2012-05-29	The Brigham And Women's Hospital, Inc	System for targeted delivery of therapeutic agents
US20090325944A1 (en) *	2006-04-12	2009-12-31	Suzanne Walker Kahne	Methods and Compositions for Modulating Glycosylation
AU2007240732B2 (en) *	2006-04-21	2013-07-04	Amgen, Inc.	Buffering agents for biopharmaceutical formulations
US20070258941A1 (en) *	2006-05-02	2007-11-08	Pfister Brian E	Methods and compositions for remediation of disc herniation by modifying structure
JP5630998B2 (ja)	2006-05-15	2014-11-26	マサチューセッツインスティテュートオブテクノロジー	機能的粒子のためのポリマー
WO2007137117A2 (en) *	2006-05-17	2007-11-29	Massachusetts Institute Of Technology	Aptamer-directed drug delivery
PL2034830T3 (pl)	2006-05-25	2015-04-30	Biogen Ma Inc	Przeciwciało anty-VLA-1 do leczenia udaru
EP2030015B1 (de) *	2006-06-02	2016-02-17	President and Fellows of Harvard College	Neugestaltung von proteinoberflächen
WO2007150030A2 (en)	2006-06-23	2007-12-27	Massachusetts Institute Of Technology	Microfluidic synthesis of organic nanoparticles
WO2008005469A2 (en)	2006-06-30	2008-01-10	Schering Corporation	Igfbp2 biomarker
CA2656620C (en)	2006-07-04	2018-03-13	Genmab A/S	Cd20 binding molecules for the treatment of copd
PT2422810E (pt)	2006-07-17	2014-12-03	Glaxosmithkline Biolog Sa	Vacina da gripe
US20080033347A1 (en) *	2006-08-03	2008-02-07	Becton, Dickinson And Company	Detachable needle syringe having reduced dead space
US7618396B2 (en) *	2006-08-09	2009-11-17	Avant Medical Corp.	Injection system with hidden needles
JP5244785B2 (ja)	2006-08-11	2013-07-24	小野薬品工業株式会社	ストローマ由来因子−１（ｓｄｆ−１）に対するモノクローナル抗体
US9115358B2 (en) *	2006-08-11	2015-08-25	President And Fellows Of Harvard College	Moenomycin biosynthesis-related compositions and methods of use thereof
WO2008073161A2 (en) *	2006-08-14	2008-06-19	Massachusetts Institute Of Technology	Hemagglutinin polypeptides, and reagents and methods relating thereto
US20090269342A1 (en) *	2006-08-14	2009-10-29	Massachusetts Institute Of Technology	Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
CA2662350A1 (en)	2006-09-05	2008-03-13	Medarex, Inc.	Antibodies to bone morphogenic proteins and receptors therefor and methods for their use
US7942845B2 (en) *	2006-09-19	2011-05-17	Bioject, Inc.	Needle-free injector and process for providing serial injections
MX2009003306A (es)	2006-10-02	2009-04-23	Medarex Inc	Anticuerpos humanos que se unen a cxcr4 y sus usos.
TW200831129A (en) *	2006-10-06	2008-08-01	Amgen Inc	Stable formulations
US7547293B2 (en)	2006-10-06	2009-06-16	Bioject, Inc.	Triggering mechanism for needle-free injector
JO3598B1 (ar)	2006-10-10	2020-07-05	Infinity Discovery Inc	الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP2433648A3 (de)	2006-10-12	2012-04-04	GlaxoSmithKline Biologicals S.A.	Impfstoff mit einem Öl-in-wasser-emulsionshilfsstoff
EA015817B1 (ru)	2006-10-12	2011-12-30	Глаксосмитклайн Байолоджикалс С.А.	Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
AU2007319605B2 (en)	2006-10-19	2011-02-17	Csl Limited	Anti-IL-13R alpha 1 antibodies and their uses thereof
EP2094247B1 (de) *	2006-10-20	2022-06-29	Amgen Inc.	Stabile polypeptid-formulierungen
CN101600450A (zh)	2006-10-20	2009-12-09	比奥根艾迪克Ma公司	利用可溶性淋巴毒素β受体的脱髓鞘病的治疗
US8618248B2 (en)	2006-10-31	2013-12-31	President And Fellows Of Harvard College	Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides
US20090124996A1 (en) *	2006-11-03	2009-05-14	Scott Heneveld	Apparatus and methods for injecting high viscosity dermal fillers
EP2097447A4 (de)	2006-11-15	2010-12-29	Medarex Inc	Monoklonale menschliche antikörper gegen btla und verfahren zu ihrer verwendung
US20100303723A1 (en) *	2006-11-20	2010-12-02	Massachusetts Institute Of Technology	Drug delivery systems using fc fragments
US8481683B2 (en)	2006-12-01	2013-07-09	Medarex, Inc.	Human antibodies that bind CD22 and uses thereof
SG177184A1 (en)	2006-12-01	2012-01-30	Anterios Inc	Amphiphilic entity nanoparticles
WO2008073856A2 (en) *	2006-12-08	2008-06-19	Massachusetts Institute Of Technology	Delivery of nanoparticles and/or agents to cells
CL2007003622A1 (es)	2006-12-13	2009-08-07	Medarex Inc	Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
MX2009006277A (es)	2006-12-14	2009-07-24	Medarex Inc	Anticuerpos humanos que se enlazan a cd70 y usos de los mismos.
CA2790018C (en) *	2006-12-21	2015-02-03	Amgen Inc.	Formulations
ES2405655T3 (es)	2006-12-26	2013-05-31	Lantheus Medical Imaging, Inc.	N-[3-bromo-4-(3-[18F]fluoropropoxi)-bencil]-guanidina para la formación de imágenes de la inervación cardíaca
WO2008083209A2 (en) *	2006-12-29	2008-07-10	Amir Genosar	Hypodermic drug delivery reservoir and apparatus
WO2008091838A2 (en)	2007-01-22	2008-07-31	Intelliject, Inc.	Medical injector with compliance tracking and monitoring
DK2118123T3 (en)	2007-01-31	2016-01-25	Dana Farber Cancer Inst Inc	Stabilized p53 peptides and uses thereof
EP2134830A2 (de) *	2007-02-09	2009-12-23	Massachusetts Institute of Technology	Oszillations-zellkultur-bioreaktor
KR101598229B1 (ko)	2007-02-16	2016-02-26	메리맥 파마슈티컬즈, 인크.	Ｅｒｂｂ3에 대한 항체 및 이의 용도
US7744563B2 (en) *	2007-02-23	2010-06-29	Bioject, Inc.	Needle-free injection devices and drug delivery systems therefor
EP1970384A1 (de)	2007-03-14	2008-09-17	Ganymed Pharmaceuticals AG	Monoklonale Antikörper zur Krebsbehandlung
JP5439193B2 (ja)	2007-03-15	2014-03-12	ユニバーシティーオブフロリダリサーチファンデーション，インク．	デスフェリチオシンポリエーテル類似体
US7960139B2 (en)	2007-03-23	2011-06-14	Academia Sinica	Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CN101679974B (zh)	2007-03-27	2015-09-30	航道生物技术有限责任公司	包含抗体替代轻链序列的构建体和文库
US8592377B2 (en)	2007-03-28	2013-11-26	President And Fellows Of Harvard College	Stitched polypeptides
JP2010523595A (ja)	2007-04-04	2010-07-15	マサチューセッツインスティテュートオブテクノロジー	ポリ（アミノ酸）ターゲッティング部分
WO2008124634A1 (en)	2007-04-04	2008-10-16	Massachusetts Institute Of Technology	Polymer-encapsulated reverse micelles
EP2152301A4 (de) *	2007-04-28	2010-07-28	Fraunhofer Usa Inc	Trypanosomaantigene, impfstoffzusammensetzungen und zugehörige verfahren
GB0708758D0 (en)	2007-05-04	2007-06-13	Powderject Res Ltd	Particle cassettes and process thereof
EP2167480A2 (de)	2007-05-23	2010-03-31	Vical Incorporated	Zusammensetzungen und verfahren zur verbesserung der immunreaktionen auf impfstoffe
EP1997832A1 (de)	2007-05-29	2008-12-03	Ganymed Pharmaceuticals AG	Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
CA2687896A1 (en)	2007-06-05	2008-12-18	Yale University	Antibody directed against the d4 ig-like domain of the kit receptor
KR20100045413A (ko) *	2007-06-14	2010-05-03	크루셀 스위츨랜드 아게	피내 인플루엔자 백신
NZ595526A (en) *	2007-06-14	2013-03-28	Biogen Idec Inc	Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant
US8524444B2 (en)	2007-06-15	2013-09-03	President And Fellows Of Harvard College	Methods and compositions for detections and modulating O-glycosylation
CA2690708A1 (en)	2007-06-26	2008-12-31	Glaxosmithkline Biologicals S.A.	Vaccine
WO2009009759A2 (en)	2007-07-11	2009-01-15	Fraunhofer Usa, Inc.	Yersinia pestis antigens, vaccine compositions, and related methods
DE102007034871A1 (de) *	2007-07-24	2009-01-29	Lts Lohmann Therapie-Systeme Ag	Einweginjektor mit handbetätigbarem Kolben
JP5588866B2 (ja)	2007-08-10	2014-09-10	メダレックスエル．エル．シー．	Ｈｃｏ３２およびｈｃｏ２７、ならびに関連実施例
WO2009026397A2 (en) *	2007-08-20	2009-02-26	Fraunhofer Usa, Inc.	Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
JP5607530B2 (ja)	2007-09-04	2014-10-15	コンピュゲンエルティーディー．	ポリペプチド並びにポリヌクレオチド、並びに薬剤および生物製剤生産のための薬剤標的としてのその利用
GB0717337D0 (en)	2007-09-06	2007-10-17	Ucb Pharma Sa	Method of treatment
EP2205074A4 (de) *	2007-10-04	2013-07-31	Harvard College	Moenomycin-analoga, syntheseverfahren und verwendung
JP2011500569A (ja) *	2007-10-12	2011-01-06	マサチューセッツインスティテュートオブテクノロジー	ワクチンナノテクノロジー
TWI489993B (zh)	2007-10-12	2015-07-01	Novartis Ag	骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）抗體組合物及使用方法
JP2011500036A (ja) *	2007-10-15	2011-01-06	ザユニバーシティーオブクイーンズランド	構築物系およびその使用
BRPI0820327A2 (pt)	2007-11-02	2020-10-06	Novartis Ag	moléculas e métodos para modulação de proteína relacionada ao receptor de lipoproteína de baixa densidade 6 (lrp6)
CN101888856B (zh)	2007-11-07	2014-08-27	塞尔德克斯医疗公司	结合人树突和上皮细胞205(dec-205)的抗体
US8617099B2 (en) *	2007-11-26	2013-12-31	Bioject Inc.	Injection device plunger auto-disable
US20090137949A1 (en) *	2007-11-26	2009-05-28	Bioject Inc.	Needle-free injection device with nozzle auto-disable
BRPI0822049B1 (pt)	2007-12-17	2021-11-16	Pfizer Limited	Composiqao farmaceutica compreendendo anticorpo antagonista anti-ngf, kit e uso de um anticorpo antingf
WO2009086250A1 (en)	2007-12-21	2009-07-09	Aesthetic Sciences Corporation	Self-contained pressurized injection device
WO2009086463A1 (en)	2007-12-28	2009-07-09	Aktivpak, Inc.	Dispenser and therapeutic package suitable for administering a therapeutic substance to a subject
DE102008011873A1 (de)	2007-12-30	2009-07-09	Idelevich, Evgeny	Applikationsvorrichtung und -verfahren zur automatisierten Medikamentenabgabe bei arteriellem Hypertonus
WO2009089119A2 (en) *	2008-01-03	2009-07-16	Massachusetts Institute Of Technology	Decoy influenza therapies
US8193182B2 (en)	2008-01-04	2012-06-05	Intellikine, Inc.	Substituted isoquinolin-1(2H)-ones, and methods of use thereof
WO2009093189A2 (en)	2008-01-22	2009-07-30	Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo - Fapesp	Peptides, compositions, and uses thereof
EP2650017A3 (de)	2008-02-05	2014-01-22	Bristol-Myers Squibb Company	Alpha-5-beta-1-Antikörper und deren Verwendungen
KR20160070165A (ko)	2008-02-08	2016-06-17	메디뮨 엘엘씨	Ｆｃ 리간드 친화성이 감소된 항-ＩＦＮＡＲ１ 항체
CA2721060A1 (en) *	2008-04-09	2009-10-15	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
ES2553113T3 (es)	2008-04-16	2015-12-04	Glaxosmithkline Biologicals S.A.	Vacuna
JP2011523353A (ja) *	2008-04-28	2011-08-11	プレジデントアンドフェロウズオブハーバードカレッジ	細胞透過のための過剰に荷電されたタンパク質
ES2563061T3 (es) *	2008-04-28	2016-03-10	Zogenix, Inc.	Nuevas formulaciones para el tratamiento de la migraña
EA201001734A1 (ru)	2008-05-02	2011-10-31	Новартис Аг	Улучшенные связывающие молекулы на основе фибронектина и их применение
US8021344B2 (en)	2008-07-28	2011-09-20	Intelliject, Inc.	Medicament delivery device configured to produce an audible output
USD994111S1 (en)	2008-05-12	2023-08-01	Kaleo, Inc.	Medicament delivery device cover
CA2725911A1 (en)	2008-05-30	2009-12-23	Dana-Farber Cancer Institute, Inc.	Methods of treating a meiotic kinesin-associated disease
WO2009158145A2 (en) *	2008-05-30	2009-12-30	Allergan, Inc.	Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form
WO2009150623A1 (en)	2008-06-13	2009-12-17	Pfizer Inc	Treatment of chronic prostatitis
WO2009155513A2 (en)	2008-06-20	2009-12-23	Novartis Ag	Immunoglobulins with reduced aggregation
KR101848095B1 (ko)	2008-06-26	2018-04-11	안테리오스, 인코퍼레이티드	경피 운반
ES2442024T3 (es)	2008-07-15	2014-02-07	Academia Sinica	Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
KR20110033304A (ko) *	2008-07-23	2011-03-30	메사추세츠 인스티튜트 오브 테크놀로지	Ｄｎａ 손상에 대해 보호하고 신경세포 생존을 증가시키는 히스톤 디아세틸라제 1 (ｈｄａｃ1)의 활성화
EP2356139A4 (de)	2008-07-23	2013-01-09	Harvard College	Ligieren zusammengehefteter polypeptide
EP2316030B1 (de)	2008-07-25	2019-08-21	Wagner, Richard W.	Proteinscreeningverfahren
AR072999A1 (es)	2008-08-11	2010-10-06	Medarex Inc	Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
EP2166021A1 (de) *	2008-09-16	2010-03-24	Ganymed Pharmaceuticals AG	Monoklonale Antikörper zur Krebsbehandlung
WO2010033882A2 (en) *	2008-09-18	2010-03-25	Becton, Dickinson And Company	Medical injector with slidable sleeve activation
US8552154B2 (en)	2008-09-26	2013-10-08	Emory University	Anti-PD-L1 antibodies and uses therefor
US8734803B2 (en)	2008-09-28	2014-05-27	Ibio Inc.	Humanized neuraminidase antibody and methods of use thereof
US8343498B2 (en)	2008-10-12	2013-01-01	Massachusetts Institute Of Technology	Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en) *	2008-10-12	2012-10-02	Massachusetts Institute Of Technology	Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343497B2 (en)	2008-10-12	2013-01-01	The Brigham And Women's Hospital, Inc.	Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en)	2008-10-12	2013-11-26	The Brigham And Women's Hospital, Inc.	Nicotine immunonanotherapeutics
CA2738243C (en)	2008-10-29	2020-09-29	Wyeth Llc	Formulations of single domain antigen binding molecules
CA2743904A1 (en)	2008-11-17	2010-05-20	The Regents Of The University Of Michigan	Cancer vaccine compositions and methods of using the same
EP2193817A1 (de) *	2008-12-02	2010-06-09	Sanofi-Aventis Deutschland GmbH	Zur Verwendung in Arzneimittelabgabevorrichtungen geeignete Antriebsanordnung und Arzneimittelabgabevorrichtung
EP3187219B2 (de) *	2008-12-02	2026-03-04	Allergan, Inc.	Injektionsvorrichtung
US20110311450A1 (en)	2008-12-08	2011-12-22	Zurit Levine	Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
WO2010067345A1 (en) *	2008-12-08	2010-06-17	Perf-Action Technologies Ltd.	Erosion prevention for o-rings in a high pressure injection device
US9637746B2 (en)	2008-12-15	2017-05-02	Greenlight Biosciences, Inc.	Methods for control of flux in metabolic pathways
EP2380023A2 (de)	2008-12-19	2011-10-26	Medirista Biotechnologies AB	Oxidiertes cardiolipin als neuer pro-entzündungsfaktor
CN105132387A (zh) *	2008-12-22	2015-12-09	绿光生物科学公司	用于制造化合物的组合物和方法
CN102341412B (zh)	2009-03-05	2018-01-05	梅达雷克斯有限责任公司	特异于cadm1 的全人抗体
GB0904540D0 (en)	2009-03-17	2009-04-29	Biotica Tech Ltd	Novel compounds and methods for their production
WO2010118159A1 (en)	2009-04-07	2010-10-14	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en)	2009-04-07	2010-10-14	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
BRPI1010517A2 (pt)	2009-04-09	2017-01-31	Amicus Therapeutics Inc	métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
JP2013525260A (ja) *	2009-04-17	2013-06-20	バイオジェン・アイデック・エムエイ・インコーポレイテッド	急性骨髄性白血病を治療するための組成物および方法
DK2421898T3 (en)	2009-04-20	2016-05-30	Oxford Biotherapeutics Ltd	Cadherin-17 SPECIFIC ANTIBODIES
US9242040B2 (en) *	2009-04-23	2016-01-26	Bayer Healthcare Llc	Syringe assemblies, methods of forming syringe assemblies and adapters for forming syringe assemblies
PE20120532A1 (es)	2009-04-27	2012-05-18	Novartis Ag	ANTICUERPOS ANTI-ActRIIB
JP2012524524A (ja)	2009-04-27	2012-10-18	ノバルティスアーゲー	ＩＬ−１２レセプターβ１サブユニットに特異的な治療用抗体の組成物および使用方法
EP2424877A4 (de)	2009-04-28	2013-01-02	Harvard College	Suprageladene proteine zur zellpenetration
SG175436A1 (en)	2009-05-04	2011-12-29	Abbott Res Bv	Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
CA2761681A1 (en)	2009-05-13	2010-11-18	Sea Lane Biotechnologies, Llc	Neutralizing molecules to influenza viruses
US8765735B2 (en) *	2009-05-18	2014-07-01	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) *	2009-05-18	2015-01-06	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) *	2009-05-18	2015-10-06	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
CA2769999C (en)	2009-06-01	2020-02-18	Shriners Hospitals For Children	A cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
US8974423B2 (en) *	2009-06-01	2015-03-10	Sanofi-Aventis Deutschland Gmbh	Resettable drug delivery device
WO2010141074A2 (en)	2009-06-01	2010-12-09	President And Fellows Of Harvard College	O-glcnac transferase inhibitors and uses thereof
MX2011012665A (es)	2009-06-04	2012-03-07	Novartis Ag	Metodos para identificacion de sitios para conjugacion de igg.
WO2010146511A1 (en)	2009-06-17	2010-12-23	Pfizer Limited	Treatment of overactive bladder
AU2010273220B2 (en)	2009-07-13	2015-10-15	President And Fellows Of Harvard College	Bifunctional stapled polypeptides and uses thereof
BR112012007875A2 (pt)	2009-07-31	2016-11-22	Medarex Inc	anticorpos totalmente humanos para btla
US8394922B2 (en)	2009-08-03	2013-03-12	Medarex, Inc.	Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
GB0913681D0 (en)	2009-08-05	2009-09-16	Glaxosmithkline Biolog Sa	Immunogenic composition
GB0914589D0 (en)	2009-08-20	2009-09-30	Biotica Tech Ltd	Novel compounds and methods for their production
WO2011029823A1 (en)	2009-09-09	2011-03-17	Novartis Ag	Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
GB0916630D0 (en)	2009-09-22	2009-11-04	Secr Defence	Antibody
CN102712675A (zh)	2009-09-22	2012-10-03	爱勒让治疗公司	拟肽大环化合物
US8784819B2 (en)	2009-09-29	2014-07-22	Ibio Inc.	Influenza hemagglutinin antibodies, compositions and related methods
GB0917817D0 (en)	2009-10-12	2009-11-25	Biotica Tech Ltd	Novel compounds and methods for their production
GB0917816D0 (en)	2009-10-12	2009-11-25	Biotica Tech Ltd	Novel compounds and methods for their production
EP2470569A1 (de)	2009-10-13	2012-07-04	Oxford Biotherapeutics Ltd.	Antikörper gegen epha10
AU2010306774A1 (en)	2009-10-14	2012-05-03	Merrimack Pharmaceuticals, Inc.	Bispecific binding agents targeting IGF-1R and ErbB3 signalling and uses thereof
KR101880411B1 (ko)	2009-10-19	2018-07-19	아미쿠스 세라퓨틱스, 인코포레이티드	중추신경계의 퇴행성 질환을 예방 및/또는 치료하는 신규 조성물
SI2995306T1 (sl)	2009-10-19	2019-04-30	Amicus Therapeutics, Inc.	Novi sestavki za preprečevanje in/ali zdravljenje motenj lizosomskega shranjevanja
WO2011051327A2 (en)	2009-10-30	2011-05-05	Novartis Ag	Small antibody-like single chain proteins
WO2011051466A1 (en)	2009-11-02	2011-05-05	Novartis Ag	Anti-idiotypic fibronectin-based binding molecules and uses thereof
US20120282276A1 (en)	2009-11-05	2012-11-08	The Regents Of The University Of Michigan	Biomarkers predictive of progression of fibrosis
EP2507265B1 (de)	2009-12-01	2016-05-11	Compugen Ltd.	Heparanase Spice-Variante T5 spezifischer Antikörper und dessen Verwendung.
US11377485B2 (en)	2009-12-02	2022-07-05	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US10087236B2 (en)	2009-12-02	2018-10-02	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US20110137260A1 (en)	2009-12-07	2011-06-09	Allergan, Inc.	Slotted syringe
EP3000885B1 (de)	2009-12-18	2018-07-25	Arrowhead Pharmaceuticals, Inc.	Organische zusammensetzungen zur behandlung von hsf1-bedingten erkrankungen
BR112012017164A2 (pt)	2009-12-22	2019-09-24	Novartis Ag	proteína de fusão de região constante de anticorpo-cd47 tetravalente
WO2011090738A2 (en)	2009-12-29	2011-07-28	Dana-Farber Cancer Institute, Inc.	Type ii raf kinase inhibitors
AU2011210840B2 (en)	2010-01-27	2014-12-11	Massachusetts Institute Of Technology	Engineered polypeptide agents for targeted broad spectrum influenza neutralization
WO2011092233A1 (en)	2010-01-29	2011-08-04	Novartis Ag	Yeast mating to produce high-affinity combinations of fibronectin-based binders
RU2015143910A (ru)	2010-02-03	2018-12-28	Инфинити Фармасьютикалз, Инк.	Ингибиторы амид-гидролазы жирных кислот
US20120296403A1 (en)	2010-02-10	2012-11-22	Novartis Ag	Methods and compounds for muscle growth
AU2011224457B2 (en)	2010-03-08	2014-11-06	Sloan-Kettering Institute For Cancer Research	Cdc7 kinase inhibitors and uses thereof
GB201003922D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Conjugation process
GB201003920D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Method of treatment
AU2011227335B2 (en)	2010-03-17	2014-11-06	Abbott Research B.V.	Anti-nerve growth factor (NGF) antibody compositions
EP2550285B1 (de)	2010-03-22	2017-07-19	President and Fellows of Harvard College	Trioxacarcine und deren verwendungen
EP2371864A1 (de)	2010-03-23	2011-10-05	Ganymed Pharmaceuticals AG	Monoklonale Antikörper zur Krebsbehandlung
US20150231215A1 (en)	2012-06-22	2015-08-20	Randolph J. Noelle	VISTA Antagonist and Methods of Use
US10745467B2 (en)	2010-03-26	2020-08-18	The Trustees Of Dartmouth College	VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
MX374075B (es)	2010-03-26	2025-03-05	Dartmouth College	Proteina mediadora de celula t regulatoria vista, agentes de enlace de vista y uso de los mismos.
US10338069B2 (en)	2010-04-12	2019-07-02	Academia Sinica	Glycan arrays for high throughput screening of viruses
EA201690310A1 (ru)	2010-04-13	2016-12-30	Селлдекс Терапьютикс Инк.	Антитела, связывающие cd27 человека, и их применение
HRP20171045T1 (hr)	2010-04-16	2017-10-06	Biogen Ma Inc.	Protutijela anti-vla-4
US9795658B2 (en)	2010-04-20	2017-10-24	Admedus Vaccines Pty Ltd	Expression system for modulating an immune response
DK2561077T3 (en)	2010-04-23	2016-08-01	Arrowhead Res Corp	Organic compositions for the treatment of beta-ENaC-related diseases
WO2011140151A1 (en)	2010-05-04	2011-11-10	Dyax Corp.	Antibodies against epidermal growth factor receptor (egfr)
EP2566512A1 (de)	2010-05-04	2013-03-13	Merrimack Pharmaceuticals, Inc.	Antikörper gegen den epidermalen wachstumsfaktorrezeptor (egfr) und ihre verwendung
US8450350B2 (en)	2010-05-05	2013-05-28	Infinity Pharmaceuticals, Inc.	Triazoles as inhibitors of fatty acid synthase
CA2798330A1 (en)	2010-05-05	2011-11-10	Infinity Pharmaceuticals, Inc.	Tetrazolones as inhibitors of fatty acid synthase
EP2566953B1 (de)	2010-05-07	2019-01-02	Greenlight Biosciences, Inc.	Verfahren zur flusssteuerung bei stoffwechselwegen druch enzymumpositionierung
ES2763815T3 (es)	2010-05-11	2020-06-01	Lantheus Medical Imaging Inc	Composiciones, métodos y sistemas para la síntesis y uso de agentes de formación de imágenes
EP2756857B1 (de)	2010-05-19	2016-05-18	Allergan, Inc.	Modulare Injektionsvorrichtung
WO2011160042A2 (en)	2010-06-18	2011-12-22	Makoto Life Sciences, Inc.	Prpk-tprkb modulators and uses thereof
AU2011272941B2 (en)	2010-06-30	2014-05-29	Compugen Ltd.	C10RF32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders
US9072713B2 (en)	2010-07-01	2015-07-07	The Texas A&M University System	Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function
CN103119062A (zh)	2010-07-16	2013-05-22	埃博灵克斯股份有限公司	修饰的单结构域抗原结合分子及其应用
WO2012019168A2 (en)	2010-08-06	2012-02-09	Moderna Therapeutics, Inc.	Engineered nucleic acids and methods of use thereof
ES2711526T3 (es)	2010-08-13	2019-05-06	Aileron Therapeutics Inc	Macrociclos peptidomiméticos
WO2012022734A2 (en)	2010-08-16	2012-02-23	Medimmune Limited	Anti-icam-1 antibodies and methods of use
EP2611922A1 (de)	2010-08-31	2013-07-10	Greenlight Biosciences, Inc.	Verfahren zur flusssteuerung bei stoffwechselwegen durch proteasemanipulation
JP5856621B2 (ja)	2010-09-15	2016-02-10	ゾゲニクスインコーポレーティッド	無針注射器および注射性能を最適化する同注射器の設計パラメータ
WO2012035518A1 (en)	2010-09-17	2012-03-22	Compugen Ltd.	Compositions and methods for treatment of drug resistant multiple myeloma
JP2013541528A (ja)	2010-09-21	2013-11-14	マサチューセッツインスティテュートオブテクノロジー	ヒト適応ｈａポリペプチド、ワクチン、およびインフルエンザの処置
WO2012040459A2 (en)	2010-09-22	2012-03-29	President And Fellows Of Harvard College	Beta-catenin targeting peptides and uses thereof
AU2011309689B2 (en)	2010-09-28	2015-01-15	Hadasit Medical Research Services & Development Ltd.	Compositions and methods for treatment of hematological malignancies
EP2625189B1 (de)	2010-10-01	2018-06-27	ModernaTX, Inc.	Manipulierte nukleinsäuren und anwendungsverfahren dafür
EP3828205A1 (de)	2010-10-01	2021-06-02	Oxford BioTherapeutics Ltd	Anti-ror1-antikörper
MX2013003599A (es)	2010-10-01	2013-07-29	Biogen Idec Inc	Interferon-beta para uso como monoterapia o en combinacion con otras terapias de cancer.
JP6029586B2 (ja)	2010-10-04	2016-11-24	マサチューセッツインスティテュートオブテクノロジー	血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法
EP2625203A1 (de)	2010-10-05	2013-08-14	Novartis AG	Anti-il12rbeta1-antikörper und ihre verwendung zur behanldung von autoimmun- und entzündungserkrankungen
AU2011325865B2 (en)	2010-11-03	2015-01-22	Construct Medical Pty Ltd	Portable vacuum device
JP2013545749A (ja)	2010-11-10	2013-12-26	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環化合物及びその使用
EP2643456B1 (de)	2010-11-24	2016-05-11	Novartis International Pharmaceutical Ltd.	Fusionsproteine mit n-acetylglucosaminyltransferase aktivitàt
US10208349B2 (en)	2011-01-07	2019-02-19	Ucb Biopharma Sprl	Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
GB201100282D0 (en)	2011-01-07	2011-02-23	Ucb Pharma Sa	Biological methods
ES2637113T3 (es)	2011-01-10	2017-10-10	Infinity Pharmaceuticals, Inc.	Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
EP3378480A1 (de)	2011-01-19	2018-09-26	Topokine Therapeutics, Inc.	Verfahren und zusammensetzungen zur behandlung des stoffwechselsyndroms
US20120328549A1 (en)	2011-01-24	2012-12-27	Anterios, Inc.	Oil compositions
US20120328701A1 (en)	2011-01-24	2012-12-27	Anterios, Inc.	Nanoparticle compositions, formulations thereof, and uses therefor
BR112013018918A2 (pt)	2011-01-24	2016-10-04	Anterios Inc	composições de nanopartículas
US8627816B2 (en)	2011-02-28	2014-01-14	Intelliject, Inc.	Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9084849B2 (en)	2011-01-26	2015-07-21	Kaleo, Inc.	Medicament delivery devices for administration of a medicament within a prefilled syringe
US8939943B2 (en)	2011-01-26	2015-01-27	Kaleo, Inc.	Medicament delivery device for administration of opioid antagonists including formulations for naloxone
CN103889219A (zh)	2011-03-03	2014-06-25	特萨斯制药有限责任公司	包含C16:1n7-棕榈油酸酯的组合物和方法
WO2012119989A2 (en)	2011-03-04	2012-09-13	Oryzon Genomics, S.A.	Methods and antibodies for the diagnosis and treatment of cancer
GB201103836D0 (en)	2011-03-07	2011-04-20	Glaxosmithkline Biolog Sa	Conjugation process
US20130281932A1 (en) *	2011-03-30	2013-10-24	Ziv Harish	Palm-based injector actuation and safety surfaces
WO2012135615A2 (en)	2011-03-30	2012-10-04	Brown University	Enopeptins, uses thereof, and methods of synthesis thereto
AU2012236099A1 (en)	2011-03-31	2013-10-03	Moderna Therapeutics, Inc.	Delivery and formulation of engineered nucleic acids
NZ713461A (en)	2011-04-15	2017-02-24	Compugen Ltd	Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
RU2013151159A (ru) *	2011-04-19	2015-05-27	ИНВИЗИДЕРМ, ЭлЭлСи	Способ создания веществ, перенасыщенных газом, устройство трансдермальной доставки и его использование
CN103533953A (zh)	2011-05-17	2014-01-22	葛兰素史密丝克莱恩生物有限公司	针对肺炎链球菌的疫苗
US8691231B2 (en)	2011-06-03	2014-04-08	Merrimack Pharmaceuticals, Inc.	Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
BR112013031762A2 (pt)	2011-06-16	2016-09-13	Novartis Ag	proteínas solúveis para utilização como terapêuticos
CA2837651A1 (en)	2011-06-21	2012-12-27	Oncofactor Corporation	Compositions and methods for the therapy and diagnosis of cancer
CA2840224C (en)	2011-06-22	2019-08-13	The General Hospital Corporation	Treatment of proteinopathies
PL2726508T3 (pl)	2011-06-28	2017-12-29	Oxford Biotherapeutics Ltd	Przeciwciała przeciwko cyklazie ADP-rybozylowej 2
US9428574B2 (en)	2011-06-30	2016-08-30	Compugen Ltd.	Polypeptides and uses thereof for treatment of autoimmune disorders and infection
JP6472999B2 (ja)	2011-07-01	2019-02-20	ノバルティスアーゲー	代謝障害を治療するための方法
AR088218A1 (es)	2011-07-19	2014-05-21	Infinity Pharmaceuticals Inc	Compuestos heterociclicos utiles como inhibidores de pi3k
HK1198443A1 (en)	2011-07-19	2015-04-24	无限药品股份有限公司	Heterocyclic compounds and uses thereof
SI2734510T1 (sl)	2011-07-22	2019-05-31	Massachusetts Institute Of Technology	Aktivatorji histon deacetilaz (HDACS) razreda I in njihove uporabe
EP2736928B1 (de)	2011-07-28	2019-01-09	i2 Pharmaceuticals, Inc.	Gegen erbb3-gerichtete sur-bindende proteine
MX2014002542A (es)	2011-08-29	2014-07-09	Infinity Pharmaceuticals Inc	Compuestos heterociclicos y usos de los mismos.
CA3185394A1 (en)	2011-09-02	2013-03-07	Arrowhead Pharmaceuticals, Inc.	Organic compositions to treat hsf1-related diseases
CN104093848A (zh)	2011-09-09	2014-10-08	绿光生物科学公司	碳青霉烯(carbapenem)的无细胞制备
CN108484449A (zh)	2011-09-09	2018-09-04	蓝瑟斯医学影像公司	用于合成和使用显像剂的组合物、方法和系统
WO2013039861A2 (en)	2011-09-12	2013-03-21	modeRNA Therapeutics	Engineered nucleic acids and methods of use thereof
WO2013043569A1 (en)	2011-09-20	2013-03-28	Vical Incorporated	Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
MX353958B (es)	2011-09-22	2018-02-07	Amgen Inc	Proteinas de union al antigeno cd27l.
WO2013049332A1 (en)	2011-09-29	2013-04-04	Infinity Pharmaceuticals, Inc.	Inhibitors of monoacylglycerol lipase and methods of their use
DE19216461T1 (de)	2011-10-03	2021-10-07	Modernatx, Inc.	Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
RU2474437C1 (ru) *	2011-10-13	2013-02-10	Борис Владимирович Смоляров	Способ осуществления безыгольной инъекции
US20130096170A1 (en)	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
TW201806968A (zh)	2011-10-18	2018-03-01	艾利倫治療公司	擬肽巨環化合物
CN104039320B (zh)	2011-11-09	2019-10-15	百时美施贵宝公司	血液恶性肿瘤用抗-cxcr4抗体的治疗
TWI679212B (zh)	2011-11-15	2019-12-11	美商安進股份有限公司	針對ｂｃｍａ之e3以及ｃｄ３的結合分子
US9382239B2 (en)	2011-11-17	2016-07-05	Dana-Farber Cancer Institute, Inc.	Inhibitors of c-Jun-N-terminal kinase (JNK)
US8603028B2 (en)	2011-11-18	2013-12-10	Allergan, Inc.	Injection device having an angled tip portion
GB201119999D0 (en)	2011-11-20	2012-01-04	Glaxosmithkline Biolog Sa	Vaccine
GB201120000D0 (en)	2011-11-20	2012-01-04	Glaxosmithkline Biolog Sa	Vaccine
JP6539046B2 (ja)	2011-12-16	2019-07-03	ユニバーシティーオブフロリダリサーチファンデーション，インク．	４’−デスフェリチオシン類似体の使用
CA3018046A1 (en)	2011-12-16	2013-06-20	Moderna Therapeutics, Inc.	Modified nucleoside, nucleotide, and nucleic acid compositions
US8426471B1 (en)	2011-12-19	2013-04-23	Topokine Therapeutics, Inc.	Methods and compositions for reducing body fat and adipocytes
US9975956B2 (en)	2011-12-22	2018-05-22	I2 Pharmaceuticals, Inc.	Surrogate binding proteins which bind DR4 and/or DR5
GB201122305D0 (en)	2011-12-23	2012-02-01	Biotica Tech Ltd	Novel compound
US8242158B1 (en)	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
RU2645252C2 (ru)	2012-01-05	2018-02-19	Глюкос Финланд Ой	Клетка нитчатых грибов с дефицитом протеаз и способы ее применения
EP2802658A2 (de)	2012-01-09	2014-11-19	Novartis AG	Rnai-wirkstoffe zur behandlung von erkrankungen im zusammenhang mit beta-catenin
US10130800B2 (en)	2012-01-27	2018-11-20	Invisiderm, Llc	Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
CA2848985A1 (en)	2012-02-01	2013-08-08	Compugen Ltd.	C10rf32 antibodies, and uses thereof for treatment of cancer
HUE033704T2 (en)	2012-02-13	2017-12-28	Bristol Myers Squibb Co	Enediyne compounds, conjugates thereof, and uses and methods therefor
BR112014020103A2 (pt)	2012-02-15	2018-10-09	Aileron Therapeutics, Inc.	macrociclos peptidomiméticos
EP2819688A4 (de)	2012-02-15	2015-10-28	Aileron Therapeutics Inc	Triazol- und thioethervernetzte peptidomimetische makrozyklen
WO2013142796A2 (en)	2012-03-23	2013-09-26	Bristol-Myers Squibb Company	Methods of treatments using ctla4 antibodies
EP2830659A1 (de)	2012-03-27	2015-02-04	Novartis AG	Behandlung von fibrose
CA2868459A1 (en)	2012-03-27	2013-10-03	Amicus Therapeutics, Inc.	Polymorphs of (3r,4r,5s)-5-(difluoromethyl)piperidine-3,4-diol fumarate and uses thereof
US9902985B2 (en)	2012-04-06	2018-02-27	President And Fellows Of Harvard College	Chemoenzymatic methods for synthesizing moenomycin analogs
US9273084B2 (en)	2012-04-06	2016-03-01	President And Fellows Of Harvard College	Moenomycin analogs, methods of synthesis, and uses thereof
EP2850091A1 (de)	2012-04-06	2015-03-25	President and Fellows of Harvard College	Verfahren und verbindungen zur identifizierung von glycosyltransferaseinhibitoren
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US10130714B2 (en)	2012-04-14	2018-11-20	Academia Sinica	Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
US9597385B2 (en)	2012-04-23	2017-03-21	Allertein Therapeutics, Llc	Nanoparticles for treatment of allergy
US20130304017A1 (en) *	2012-05-09	2013-11-14	Bioject, Inc.	Peformance of needle-free injection according to known relationships
WO2013167153A1 (en)	2012-05-09	2013-11-14	Ganymed Pharmaceuticals Ag	Antibodies useful in cancer diagnosis
US9969794B2 (en)	2012-05-10	2018-05-15	Visterra, Inc.	HA binding agents
SG11201406769RA (en)	2012-05-10	2014-11-27	Massachusetts Inst Technology	Agents for influenza neutralization
US9399672B2 (en)	2012-05-17	2016-07-26	The United States Of America, As Represented By The Secretary Department Of Health And Human Services	Hepatitis C virus neutralizing antibody
AR091069A1 (es)	2012-05-18	2014-12-30	Amgen Inc	Proteinas de union a antigeno dirigidas contra el receptor st2
US9522235B2 (en)	2012-05-22	2016-12-20	Kaleo, Inc.	Devices and methods for delivering medicaments from a multi-chamber container
EP2852610B1 (de)	2012-05-23	2018-07-11	Glykos Finland Oy	Herstellung von fucosylierten glykoproteinen
WO2013176754A1 (en)	2012-05-24	2013-11-28	Abbvie Inc.	Novel purification of antibodies using hydrophobic interaction chromatography
EP3530283A1 (de)	2012-06-05	2019-08-28	The Australian National University	Impfung mit interleukin-4-antagonisten
GB201210082D0 (en) *	2012-06-07	2012-07-25	Consort Medical Plc	Improved syringe
US9890215B2 (en)	2012-06-22	2018-02-13	King's College London	Vista modulators for diagnosis and treatment of cancer
JP6285923B2 (ja)	2012-06-22	2018-02-28	トラスティーズ・オブ・ダートマス・カレッジ	新規ＶＩＳＴＡ−Ｉｇコンストラクト及び自己免疫、アレルギー性及び炎症性障害の処置のためのＶＩＳＴＡ−Ｉｇの使用
UY34887A (es)	2012-07-02	2013-12-31	Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware	Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
USD695892S1 (en)	2012-07-23	2013-12-17	Pharmajet, Inc.	Needle-free syringe
AU2013301312A1 (en)	2012-08-06	2015-03-19	Glaxosmithkline Biologicals S.A.	Method for eliciting in infants an immune response against RSV and B. pertussis
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
AU2013203000B9 (en)	2012-08-10	2017-02-02	Lantheus Medical Imaging, Inc.	Compositions, methods, and systems for the synthesis and use of imaging agents
US10309430B2 (en) *	2012-08-10	2019-06-04	Confluent Surgical, Inc.	Pneumatic actuation assembly
WO2014028463A1 (en)	2012-08-14	2014-02-20	Allergan, Inc.	Syringe for mixing and dispensing adipose tissue
WO2014031498A1 (en)	2012-08-18	2014-02-27	Academia Sinica	Cell-permeable probes for identification and imaging of sialidases
US9381244B2 (en)	2012-09-07	2016-07-05	King's College London	VISTA modulators for diagnosis and treatment of cancer
WO2014052647A2 (en)	2012-09-26	2014-04-03	President And Fellows Of Harvard College	Proline-locked stapled peptides and uses thereof
US20150225471A1 (en)	2012-10-01	2015-08-13	President And Fellows Of Harvard College	Stabilized polypeptide insulin receptor modulators
RS58700B1 (sr)	2012-10-12	2019-06-28	Broad Inst Inc	Gsk3 inhibitori i postupci njihove primene
EP2909194A1 (de)	2012-10-18	2015-08-26	Dana-Farber Cancer Institute, Inc.	Hemmer der cyclinabhängigen kinase 7 (cdk7)
WO2014063054A1 (en)	2012-10-19	2014-04-24	Dana-Farber Cancer Institute, Inc.	Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
USRE48175E1 (en)	2012-10-19	2020-08-25	Dana-Farber Cancer Institute, Inc.	Hydrophobically tagged small molecules as inducers of protein degradation
US9675754B2 (en)	2012-10-24	2017-06-13	Nuance Designs, LLC	Autoinjector
WO2014065822A1 (en)	2012-10-26	2014-05-01	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Hepatitis c virus neutralizing epitopes, antibodies, and methods
AU2013337717B2 (en)	2012-11-01	2018-10-25	Infinity Pharmaceuticals, Inc.	Treatment of cancers using PI3 kinase isoform modulators
WO2014071241A1 (en)	2012-11-01	2014-05-08	Aileron Therapeutics, Inc.	Disubstituted amino acids and methods of preparation and use thereof
EP2917203B1 (de)	2012-11-02	2019-04-03	Dana-Farber Cancer Institute, Inc.	Verfahren zur identifizierung von myc inhibitoren
CN104936632B (zh) *	2012-11-13	2017-08-04	康斯特鲁科特医疗有限公司	便携式抽吸装置
WO2014081941A1 (en)	2012-11-21	2014-05-30	Topokine Therapeutics, Inc.	Methods and compositions for locally increasing body fat
PL2922554T3 (pl)	2012-11-26	2022-06-20	Modernatx, Inc.	Na zmodyfikowany na końcach
JP6408478B2 (ja)	2012-11-26	2018-10-17	プレジデントアンドフェローズオブハーバードカレッジ	トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
AU2013359419B2 (en)	2012-12-10	2018-03-15	Biogen Ma Inc.	Anti-blood dendritic cell antigen 2 antibodies and uses thereof
USD690416S1 (en)	2012-12-12	2013-09-24	Pharmajet, Inc.	Needle-free syringe
PL2935320T3 (pl)	2012-12-18	2020-03-31	Novartis Ag	Stabilizowane polipeptydy insulinopodobnego czynnika wzrostu
CA2899363A1 (en)	2012-12-21	2014-06-26	Epizyme, Inc.	Prmt5 inhibitors and uses thereof
CA2894126A1 (en)	2012-12-21	2014-06-26	Epizyme, Inc.	Prmt5 inhibitors and uses thereof
US9745291B2 (en)	2012-12-21	2017-08-29	Epizyme, Inc.	PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
DK2935222T3 (en)	2012-12-21	2019-01-07	Epizyme Inc	PRMT5 INHIBITORS AND APPLICATIONS THEREOF
WO2014106096A1 (en)	2012-12-27	2014-07-03	Kaleo, Inc.	Devices, systems and methods for locating and interacting with medicament delivery systems
AU2013374345A1 (en)	2013-01-17	2015-08-06	Moderna Therapeutics, Inc.	Signal-sensor polynucleotides for the alteration of cellular phenotypes
EP2948478B1 (de)	2013-01-25	2019-04-03	Amgen Inc.	Antikörper gegen cdh19 für melanome
JO3519B1 (ar)	2013-01-25	2020-07-05	Amgen Inc	تركيبات أجسام مضادة لأجل cdh19 و cd3
US11576958B2 (en)	2013-02-07	2023-02-14	Children's Medical Center Corporation	Protein antigens that provide protection against pneumococcal colonization and/or disease
US20140335504A1 (en)	2013-02-07	2014-11-13	Massachusetts Institute Of Technology	Human adaptation of h5 influenza
LT2953969T (lt)	2013-02-08	2019-12-10	Novartis Ag	Anti-il-17a antikūnai ir jų panaudojimas autoimuninių ir uždegiminių ligų gydymui
LT2956173T (lt)	2013-02-14	2017-06-26	Bristol-Myers Squibb Company	Tubulizino junginiai, gavimo ir panaudojimo būdai
CA2902068C (en)	2013-02-28	2023-10-03	Caprion Proteomics Inc.	Tuberculosis biomarkers and uses thereof
EP3391898A3 (de)	2013-03-13	2019-02-13	President and Fellows of Harvard College	Gestapelte und geheftete polypeptide und verwendungen davon
EP2968391A1 (de)	2013-03-13	2016-01-20	Moderna Therapeutics, Inc.	Langlebige polynukleotidmoleküle
BR112015017307A2 (pt)	2013-03-14	2017-11-21	Abbvie Inc	composições de espécies com baixa acidez e métodos para produção e uso das mesmas
CA2899449A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	Low acidic species compositions and methods for producing the same using displacement chromatography
US9580486B2 (en)	2013-03-14	2017-02-28	Amgen Inc.	Interleukin-2 muteins for the expansion of T-regulatory cells
WO2014144466A1 (en)	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Anti-alpha v beta 6 antibodies and uses thereof
US9308236B2 (en)	2013-03-15	2016-04-12	Bristol-Myers Squibb Company	Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
PL2970449T3 (pl)	2013-03-15	2020-04-30	Amgen Research (Munich) Gmbh	Jednołańcuchowe cząsteczki wiążące zawierające N-końcowy ABP
WO2014151386A1 (en)	2013-03-15	2014-09-25	Infinity Pharmaceuticals, Inc.	Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
WO2014143739A2 (en)	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Anti-alpha v beta 6 antibodies and uses thereof
EP2970446A1 (de)	2013-03-15	2016-01-20	Amgen Research (Munich) GmbH	Antikörperkonstrukte für influenza m2 und cd3
JP2016515120A (ja)	2013-03-15	2016-05-26	バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎＭＡＩｎｃ．	抗アルファｖベータ５抗体を用いた急性腎損傷の治療及び予防
KR102233251B1 (ko)	2013-04-03	2021-03-26	엔-폴드 엘엘씨	신규 나노입자 조성물
JP6437523B2 (ja)	2013-04-04	2018-12-12	プレジデントアンドフェローズオブハーバードカレッジ	マクロライドならびにそれらの調製および使用の方法
WO2014169073A1 (en)	2013-04-09	2014-10-16	Massachusetts Institute Of Technology	Drug delivery polymer and uses thereof
WO2014179464A1 (en)	2013-04-30	2014-11-06	Massachusetts Institute Of Technology	Human adaptation of h3 influenza
WO2014179562A1 (en)	2013-05-01	2014-11-06	Massachusetts Institute Of Technology	1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
NO2753788T3 (de)	2013-05-10	2018-06-16
WO2014186504A1 (en)	2013-05-15	2014-11-20	Topokine Therapeutics, Inc.	Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
US20140350516A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Mechanical syringe accessory
US20140350518A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Syringe extrusion accessory
HUE056580T2 (hu)	2013-05-30	2022-02-28	Kiniksa Pharmaceuticals Ltd	Onkosztatin-M-receptor antigénjét kötõ fehérjék
CA2914284A1 (en)	2013-05-30	2014-12-04	Infinity Pharmaceuticals, Inc.	Treatment of cancers using pi3 kinase isoform modulators
US10526375B2 (en)	2013-06-05	2020-01-07	Massachusetts Institute Of Technology	Human Adaptation of H7 HA
CA2914815A1 (en)	2013-06-11	2014-12-18	Kala Pharmaceuticals, Inc.	Urea derivatives and uses thereof
JP2016523241A (ja)	2013-06-14	2016-08-08	プレジデントアンドフェローズオブハーバードカレッジ	安定化されたポリペプチドインスリン受容体調節剤
ES2909438T3 (es)	2013-06-26	2022-05-06	Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh	Enantiómero (S) de mepacina como inhibidor de paracaspasa (MALT1) para tratar cáncer
EP3013365B1 (de)	2013-06-26	2019-06-05	Academia Sinica	Rm2-antigene und verwendung davon
EP3013347B1 (de)	2013-06-27	2019-12-11	Academia Sinica	Glykankonjugate und verwendung davon
US9975896B2 (en)	2013-07-25	2018-05-22	Dana-Farber Cancer Institute, Inc.	Inhibitors of transcription factors and uses thereof
AU2014306074B2 (en)	2013-08-05	2018-08-30	Greenlight Biosciences, Inc.	Engineered proteins with a protease cleavage site
MX2016001695A (es)	2013-08-05	2016-05-02	Glaxosmithkline Biolog Sa	Composiciones inmunogenas de combinacion.
TWI532511B (zh) *	2013-08-16	2016-05-11	京華堂實業股份有限公司	無針型注射系統及其注射方法
JP6486368B2 (ja)	2013-09-06	2019-03-20	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
AR097648A1 (es)	2013-09-13	2016-04-06	Amgen Inc	Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
WO2015050959A1 (en)	2013-10-01	2015-04-09	Yale University	Anti-kit antibodies and methods of use thereof
US20160271265A1 (en)	2013-10-02	2016-09-22	Novartis Ag	Insulin-like growth factor mimetics for use in therapy
WO2015051234A2 (en)	2013-10-04	2015-04-09	Biogen Idec Ma Inc.	Tweak antagonists for treating lupus nephritis and muscle atrophy
US9751888B2 (en)	2013-10-04	2017-09-05	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
PT3052485T (pt)	2013-10-04	2021-10-22	Infinity Pharmaceuticals Inc	Compostos heterocíclicos e suas utilizações
CN105745224B (zh)	2013-10-11	2019-11-05	牛津生物疗法有限公司	用于治疗癌症的针对ly75的偶联抗体
WO2015057894A1 (en)	2013-10-15	2015-04-23	Massachusetts Institute Of Technology	Methods for treating polycystic kidney disease and polycystic liver disease
US9902986B2 (en)	2013-10-16	2018-02-27	Massachusetts Institute Of Technology	Enterobactin conjugates and uses thereof
WO2015057939A1 (en)	2013-10-18	2015-04-23	Biogen Idec Ma Inc.	Anti-s1p4 antibodies and uses thereof
EP3057956B1 (de)	2013-10-18	2021-05-05	Dana-Farber Cancer Institute, Inc.	Polycyclische inhibitoren der cyclin-dependent-kinase 7 (cdk7)
WO2015058126A1 (en)	2013-10-18	2015-04-23	Syros Pharmaceuticals, Inc.	Heteroaromatic compounds useful for the treatment of prolferative diseases
US20160244452A1 (en)	2013-10-21	2016-08-25	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US9458169B2 (en)	2013-11-01	2016-10-04	Kala Pharmaceuticals, Inc.	Crystalline forms of therapeutic compounds and uses thereof
UY35874A (es)	2013-12-12	2015-07-31	Novartis Ag	Un proceso para la preparación de una composición de proteínas pegiladas
CN106029697B (zh)	2013-12-20	2021-06-04	英特维特国际股份有限公司	具有经修饰的ch2-ch3序列的犬抗体
TWI670283B (zh)	2013-12-23	2019-09-01	美商建南德克公司	抗體及使用方法
AU2014369834B2 (en)	2013-12-24	2018-12-20	President And Fellows Of Harvard College	Cortistatin analogues and syntheses and uses thereof
WO2015097536A2 (en)	2013-12-24	2015-07-02	Janssen Pharmaceutical Nv	Anti-vista antibodies and fragments
US11014987B2 (en)	2013-12-24	2021-05-25	Janssen Pharmaceutics Nv	Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
AU2015206370A1 (en)	2014-01-16	2016-07-07	Academia Sinica	Compositions and methods for treatment and detection of cancers
US10150818B2 (en)	2014-01-16	2018-12-11	Academia Sinica	Compositions and methods for treatment and detection of cancers
US10793571B2 (en)	2014-01-31	2020-10-06	Dana-Farber Cancer Institute, Inc.	Uses of diazepane derivatives
US9598438B2 (en)	2014-02-12	2017-03-21	Amicus Therapeutics, Inc.	Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC
MX2016011517A (es)	2014-03-07	2017-04-13	Univ Arizona	Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.
MX382033B (es)	2014-03-19	2025-03-13	Infinity Pharmaceuticals Inc	Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
CN106415244B (zh)	2014-03-27	2020-04-24	中央研究院	反应性标记化合物及其用途
DK3122375T3 (da)	2014-03-28	2021-05-25	Univ Washington Through Its Center For Commercialization	Vacciner mod bryst- og ovariecancer
US9675627B2 (en)	2014-04-14	2017-06-13	Amicus Therapeutics, Inc.	Dosing regimens for treating and/or preventing cerebral amyloidoses
US9862688B2 (en)	2014-04-23	2018-01-09	Dana-Farber Cancer Institute, Inc.	Hydrophobically tagged janus kinase inhibitors and uses thereof
WO2015164614A1 (en)	2014-04-23	2015-10-29	Dana-Farber Cancer Institute, Inc.	Janus kinase inhibitors and uses thereof
WO2015168079A1 (en)	2014-04-29	2015-11-05	Infinity Pharmaceuticals, Inc.	Pyrimidine or pyridine derivatives useful as pi3k inhibitors
WO2015168380A1 (en)	2014-04-30	2015-11-05	Massachusetts Institute Of Technology	Siderophore-based immunization against gram-negative bacteria
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
CA2949535C (en)	2014-05-21	2023-09-12	President And Fellows Of Harvard College	Ras inhibitory peptides and uses thereof
CA2950415A1 (en)	2014-05-27	2015-12-03	Academia Sinica	Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en)	2014-05-27	2018-11-06	Academia Sinica	Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CN106661099A (zh)	2014-05-27	2017-05-10	中央研究院	抗her2醣抗体及其用途
JP7093612B2 (ja)	2014-05-27	2022-06-30	アカデミアシニカ	Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法
WO2015184001A1 (en)	2014-05-28	2015-12-03	Academia Sinica	Anti-tnf-alpha glycoantibodies and uses thereof
JP6612017B2 (ja) *	2014-06-03	2019-11-27	株式会社ダイセル	無針注射器による注射システム
PE20170441A1 (es)	2014-06-06	2017-04-26	Bristol Myers Squibb Co	Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
US11123426B2 (en)	2014-06-11	2021-09-21	The Trustees Of Dartmouth College	Use of vista agonists and antagonists to suppress or enhance humoral immunity
MX384992B (es)	2014-06-13	2025-03-14	Glaxosmithkline Biologicals Sa	Combinaciones inmunógenas.
EP3778584A1 (de)	2014-06-19	2021-02-17	ARIAD Pharmaceuticals, Inc.	Herstellungsverfahren von 2-chloro-4-heteroaryl-pyrimine derivaten
EP2959931A1 (de)	2014-06-24	2015-12-30	LTS LOHMANN Therapie-Systeme AG	Nadellose Injektionsvorrichtung
EP3161001A2 (de)	2014-06-25	2017-05-03	Novartis AG	Il17-a spezifische antikörper die mit hyaluronan bindenden peptid-marker fusioniert sind
WO2015200425A1 (en)	2014-06-27	2015-12-30	Topokine Therapeutics, Inc.	Topical dosage regimen
US9840479B2 (en)	2014-07-02	2017-12-12	Massachusetts Institute Of Technology	Polyamine-fatty acid derived lipidoids and uses thereof
WO2016004197A1 (en)	2014-07-03	2016-01-07	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
WO2016007764A1 (en)	2014-07-09	2016-01-14	Abbvie Inc.	Methods for modulating the glycosylation profile of recombinant proteins using non-commonly used sugars
US9517307B2 (en)	2014-07-18	2016-12-13	Kaleo, Inc.	Devices and methods for delivering opioid antagonists including formulations for naloxone
US10759836B2 (en)	2014-07-18	2020-09-01	University Of Washington	Cancer vaccine compositions and methods of use thereof
MX384418B (es)	2014-07-31	2025-03-14	Amgen Res Munich Gmbh	Constructo de anticuerpo de cadena individual biespecífico con distribución mejorada de tejido.
UY36245A (es)	2014-07-31	2016-01-29	Amgen Res Munich Gmbh	Constructos de anticuerpos para cdh19 y cd3
EP3174901B1 (de)	2014-07-31	2019-06-26	Amgen Research (Munich) GmbH	Optimierte artenübergreifende spezifische bispezifische einkettige antikörperkonstrukte
EP2979714A1 (de)	2014-08-02	2016-02-03	LTS LOHMANN Therapie-Systeme AG	Nadellose Injektionsvorrichtung aufweisend eine Membran
EP4108256A1 (de)	2014-08-11	2022-12-28	University of Massachusetts	Anti-ospa-antikörper und verfahren zur verwendung
US10736966B2 (en)	2014-08-12	2020-08-11	Massachusetts Institute Of Technology	Brush-poly (glycoamidoamine)-lipids and uses thereof
JO3663B1 (ar)	2014-08-19	2020-08-27	Merck Sharp & Dohme	الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
MD4733C1 (ro)	2014-08-19	2021-07-31	Merck Sharp & Dohme Corp	Anticorpi anti-TIGIT
EP3185885B1 (de)	2014-08-26	2020-08-19	Compugen Ltd.	Polypeptide und verwendungen davon als arzneimittel zur behandlung von autoimmunerkrankungen
EP2993174A1 (de)	2014-09-08	2016-03-09	Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH	Pyrazolopyridinderivate und deren Verwendung in der Therapie
TWI745275B (zh)	2014-09-08	2021-11-11	中央研究院	使用醣脂激活人類ｉＮＫＴ細胞
AU2015320545C1 (en)	2014-09-24	2020-05-14	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles and formulations thereof
EP3197478A4 (de)	2014-09-24	2018-05-30	Aileron Therapeutics, Inc.	Peptidomimetische makrozyklen und verwendungen davon
US10226585B2 (en)	2014-10-01	2019-03-12	Allergan, Inc.	Devices for injection and dosing
JP2017531642A (ja)	2014-10-03	2017-10-26	マサチューセッツインスティテュートオブテクノロジー	エボラ糖タンパク質に結合する抗体およびその使用
WO2016054491A1 (en)	2014-10-03	2016-04-07	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US9732119B2 (en)	2014-10-10	2017-08-15	Bristol-Myers Squibb Company	Immunomodulators
UA119794C2 (uk)	2014-10-21	2019-08-12	Аріад Фармасьютикалз, Інк.	Кристалічна форма 5-хлор-n4-[2-(диметилфосфорил)феніл]-n2-{2-метокси-4-[4-(4-метилпіперазин-1-іл)піперидин-1-іл]}піримідин-2,4-діаміну
EP3011988A1 (de)	2014-10-22	2016-04-27	LTS LOHMANN Therapie-Systeme AG	Nadellose Injektionsvorrichtung aufweisend ein Gel und eine Membran
EP3212222A2 (de)	2014-10-28	2017-09-06	INSERM - Institut National de la Santé et de la Recherche Médicale	Zusammensetzungen und verfahren für antigenspezifische toleranz
WO2016077125A1 (en)	2014-11-10	2016-05-19	Moderna Therapeutics, Inc.	Alternative nucleic acid molecules containing reduced uracil content and uses thereof
WO2016075137A1 (en)	2014-11-10	2016-05-19	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
US10077287B2 (en)	2014-11-10	2018-09-18	Bristol-Myers Squibb Company	Tubulysin analogs and methods of making and use
US9856292B2 (en)	2014-11-14	2018-01-02	Bristol-Myers Squibb Company	Immunomodulators
AU2015349878A1 (en)	2014-11-21	2017-05-25	Bristol-Myers Squibb Company	Antibodies against CD73 and uses thereof
JP6668345B2 (ja)	2014-11-21	2020-03-18	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	修飾された重鎖定常領域を含む抗体
US10253045B2 (en)	2014-11-26	2019-04-09	Kala Pharmaceuticals, Inc.	Crystalline forms of a therapeutic compound and uses thereof
WO2016087514A1 (en)	2014-12-02	2016-06-09	Cemm - Forschungszentrum Für Molekulare Medizin Gmbh	Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies
CA2969730A1 (en)	2014-12-05	2016-06-09	Immunext, Inc.	Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
EP3230272B1 (de)	2014-12-10	2020-08-19	Kala Pharmaceuticals, Inc.	1-amino-triazol(1,5-a)pyridin-substituiertes harnstoffderivat und verwendungen davon
US9861680B2 (en)	2014-12-18	2018-01-09	Bristol-Myers Squibb Company	Immunomodulators
WO2016097865A1 (en)	2014-12-19	2016-06-23	Regenesance B.V.	Antibodies that bind human c6 and uses thereof
JP6180663B2 (ja)	2014-12-23	2017-08-16	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｔｉｇｉｔに対する抗体
EP3237066B1 (de)	2014-12-23	2020-10-21	Sloan-Kettering Institute for Cancer Research	Polymorph von granaticin b
JP6854762B2 (ja)	2014-12-23	2021-04-07	ダナ−ファーバーキャンサーインスティテュート，インコーポレイテッド	サイクリン依存性キナーゼ７（ｃｄｋ７）の阻害剤
ES2924394T3 (es)	2015-01-09	2022-10-06	Adalta Ltd	Moléculas de unión a CXCR4
BR112017014937A2 (pt)	2015-01-14	2018-03-13	Bristol-Myers Squibb Company	dímeros de benzodiazepina ligados em ponte a heteroarileno, conjugados dos mesmos, e métodos de preparação e uso
US10495645B2 (en)	2015-01-16	2019-12-03	Academia Sinica	Cancer markers and methods of use thereof
US9975965B2 (en)	2015-01-16	2018-05-22	Academia Sinica	Compositions and methods for treatment and detection of cancers
JP6779887B2 (ja)	2015-01-24	2020-11-04	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	新規なグリカンコンジュゲートおよびその使用方法
US20160222060A1 (en)	2015-02-04	2016-08-04	Bristol-Myers Squibb Company	Immunomodulators
US10983128B2 (en)	2015-02-05	2021-04-20	Bristol-Myers Squibb Company	CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
WO2016144773A1 (en)	2015-03-06	2016-09-15	Abbvie Inc.	Arabinosylated glycoproteins
WO2016145085A2 (en)	2015-03-09	2016-09-15	Celldex Therapeutics, Inc.	Cd27 agonists
BR112017019272A2 (pt)	2015-03-10	2018-05-02	Allergan Pharmaceuticals Holdings Ireland Unlimited Company	injetor de múltiplas agulhas
US9809625B2 (en)	2015-03-18	2017-11-07	Bristol-Myers Squibb Company	Immunomodulators
WO2016154058A1 (en)	2015-03-20	2016-09-29	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles and uses thereof
WO2016154010A1 (en)	2015-03-20	2016-09-29	Makidon Paul	Immunogenic compositions for use in vaccination against bordetella
WO2016154427A2 (en)	2015-03-24	2016-09-29	Kaleo, Inc.	Devices and methods for delivering a lyophilized medicament
USRE50776E1 (en)	2015-03-27	2026-02-03	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinases
BR112017020690A2 (pt)	2015-03-30	2018-06-26	Greenlight Biosciences Inc	produção livre de células de ácido ribonucleico
CA2980087A1 (en)	2015-04-02	2016-10-06	Intervet International B.V.	Antibodies to canine interleukin-4 receptor alpha
WO2016162405A1 (en)	2015-04-10	2016-10-13	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Pyrone derivatives for use as antiviral agents
CR20170510A (es)	2015-04-10	2018-02-26	Amgen Inc	Muteínas de interuquina 2 para la expansión de células t regulatorias
CN107750255B (zh)	2015-04-17	2022-08-30	安进研发（慕尼黑）股份有限公司	用于cdh3和cd3的双特异性抗体构建体
EP3288557A4 (de)	2015-04-27	2018-11-07	University of Florida Research Foundation, Inc.	Metabolisch programmierte metallchelatoren und verwendungen davon
TW201702271A (zh)	2015-04-30	2017-01-16	哈佛大學校長及研究員協會	治療代謝病症之抗－ａｐ２抗體及抗原結合劑
WO2016178591A2 (en)	2015-05-05	2016-11-10	Gene Predit, Sa	Genetic markers and treatment of male obesity
CN115043943A (zh)	2015-05-15	2022-09-13	综合医院公司	拮抗性抗肿瘤坏死因子受体超家族抗体
EP3297676A2 (de)	2015-05-22	2018-03-28	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Kombination aus trpm8-agonist und nachr-agonist zur behandlung von obesitas und verwandten erkrankungen sowie zur gewichtsreduzierung
JP6851322B2 (ja)	2015-05-27	2021-03-31	ユーシービーバイオファルマエスアールエル	神経疾患を治療する方法
WO2016196895A1 (en) *	2015-06-05	2016-12-08	Joslin Diabetes Center, Inc.	Methods amd compositions for promoting thermogenic potential
WO2016201370A1 (en)	2015-06-12	2016-12-15	Dana-Farber Cancer Institute, Inc.	Combination therapy of transcription inhibitors and kinase inhibitors
US20160361496A1 (en) *	2015-06-15	2016-12-15	Nuance Designs Of Ct, Llc	Autoinjector
JP2017000667A (ja)	2015-06-16	2017-01-05	国立大学法人三重大学	無針注射器及びそれを用いた注射対象領域へのｄｎａ導入方法
WO2016205691A1 (en)	2015-06-19	2016-12-22	Massachusetts Institute Of Technology	Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
CA2990360C (en)	2015-06-24	2024-02-13	Janssen Pharmaceutica Nv	Anti-vista antibodies and fragments
UY36751A (es)	2015-06-26	2017-01-31	Novartis Ag	Anticuerpos de factor xi y métodos de uso
CN107922500A (zh)	2015-06-29	2018-04-17	洛克菲勒大学	具有增强的激动剂活性的抗cd40抗体
US10576206B2 (en)	2015-06-30	2020-03-03	Kaleo, Inc.	Auto-injectors for administration of a medicament within a prefilled syringe
US10059741B2 (en)	2015-07-01	2018-08-28	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles
US20180305451A1 (en)	2015-07-13	2018-10-25	Compugen Ltd.	Hide1 compositions and methods
TWI796283B (zh)	2015-07-31	2023-03-21	德商安美基研究（慕尼黑）公司	Ｍｓｌｎ及ｃｄ３抗體構築體
EA039859B1 (ru)	2015-07-31	2022-03-21	Эмджен Рисерч (Мюник) Гмбх	Биспецифические конструкты антител, связывающие egfrviii и cd3
TWI793062B (zh)	2015-07-31	2023-02-21	德商安美基研究（慕尼黑）公司	Ｄｌｌ３及ｃｄ３抗體構築體
TWI717375B (zh)	2015-07-31	2021-02-01	德商安美基研究（慕尼黑）公司	Ｃｄ７０及ｃｄ３抗體構築體
TWI829617B (zh)	2015-07-31	2024-01-21	德商安美基研究（慕尼黑）公司	Ｆｌｔ３及ｃｄ３抗體構築體
TWI744242B (zh)	2015-07-31	2021-11-01	德商安美基研究（慕尼黑）公司	Egfrviii及cd3抗體構築體
JO3620B1 (ar)	2015-08-05	2020-08-27	Amgen Res Munich Gmbh	مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم
US10179128B2 (en)	2015-08-31	2019-01-15	Amicus Therapeutics, Inc.	Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
AU2016319125B2 (en)	2015-09-09	2021-04-08	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinases
WO2017044633A1 (en)	2015-09-10	2017-03-16	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles as modulators of mcl-1
WO2017048702A1 (en)	2015-09-14	2017-03-23	Infinity Pharmaceuticals, Inc.	Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
EP3350333B2 (de)	2015-09-17	2025-08-06	ModernaTX, Inc.	Polynukleotide mit stabilisierendem schwanzbereich
JP6948313B6 (ja)	2015-09-17	2022-01-14	モデルナティエックスインコーポレイテッド	治療剤の細胞内送達のための化合物および組成物
RU2638457C2 (ru)	2015-09-28	2017-12-13	Общество С Ограниченной Ответственностью "Онкомакс"	Антитела, специфически связывающие рецептор 1 типа фактора роста фибробластов, применение антител для лечения онкологического заболевания, способ получения антител
EP3355914B1 (de)	2015-09-29	2024-03-06	The General Hospital Corporation	Eine bcg-haltige zusammensetzung zur cholesterolsenkung.
PL3356386T3 (pl)	2015-09-30	2024-08-05	Rhythm Pharmaceuticals, Inc.	Sposób leczenia zaburzeń związanych ze szlakiem receptora melanokortyny 4
WO2017059389A1 (en)	2015-10-01	2017-04-06	Kythera Biopharmaceuticals, Inc.	Compositions comprising a statin for use in methods of adipolysis
GB201518684D0 (en)	2015-10-21	2015-12-02	Glaxosmithkline Biolog Sa	Vaccine
JO3555B1 (ar)	2015-10-29	2020-07-05	Merck Sharp & Dohme	جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
CN118725134A (zh)	2015-11-08	2024-10-01	豪夫迈·罗氏有限公司	筛选多特异性抗体的方法
EP3374390A1 (de)	2015-11-13	2018-09-19	Visterra, Inc.	Zusammensetzungen und verfahren zur behandlung und vorbeugung von grippe
AU2016356780A1 (en)	2015-11-19	2018-06-28	Bristol-Myers Squibb Company	Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
UY36990A (es)	2015-11-21	2017-11-30	Fundació Privada Inst De Recerca De La Sida-Caixa (Irsicaixa)	Derivados de anticuerpos contra el vih con actividad dual antiviral e inmunomodulatoria
WO2017095875A1 (en)	2015-11-30	2017-06-08	Bristol-Myers Squibb Company	Anti human ip-10 antibodies and their uses
SI3383920T1 (sl)	2015-11-30	2024-06-28	The Regents Of The University Of California	Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic
WO2017096432A1 (en)	2015-12-09	2017-06-15	Admedus Vaccines Pty Ltd	Immunomodulating composition for treatment
CA3005696A1 (en)	2015-12-18	2017-06-22	Intervet International B.V.	Caninized human antibodies to human and canine il-4r alpha
LT3394030T (lt)	2015-12-22	2022-04-11	Modernatx, Inc.	Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
RU2757314C2 (ru)	2016-01-22	2021-10-13	Мерк Шарп И Доум Корп.	Антитела против фактора свертывания xi
JOP20170017B1 (ar)	2016-01-25	2021-08-17	Amgen Res Munich Gmbh	تركيب صيدلي يتضمن تركيبات جسم مضاد ثنائي الاختصاص
IL313507A (en)	2016-02-03	2024-08-01	Amgen Res Munich Gmbh	Constructs of bispecific antibodies to BCMA and CD3 that bind to T cells, preparations containing the same and uses thereof
EA201891753A1 (ru)	2016-02-03	2019-01-31	Эмджен Рисерч (Мюник) Гмбх	Биспецифические конструкции антител к psma и cd3, вовлекающие т-клетки
WO2017137830A1 (en)	2016-02-12	2017-08-17	Janssen Pharmaceutica Nv	Anti-vista (b7h5) antibodies
AU2017219254B2 (en)	2016-02-17	2019-12-12	Novartis Ag	TGFbeta 2 antibodies
AU2017222564A1 (en)	2016-02-24	2018-09-06	Visterra, Inc.	Formulations of antibody molecules to influenza virus
ES2985566T3 (es)	2016-03-04	2024-11-06	Univ Rockefeller	Anticuerpos contra CD40 con actividad agonista mejorada
US10143746B2 (en)	2016-03-04	2018-12-04	Bristol-Myers Squibb Company	Immunomodulators
EP3423494A1 (de)	2016-03-04	2019-01-09	Bristol-Myers Squibb Company	Kombinationstherapie mit anti-cd73-antikörpern
EP3426693A4 (de)	2016-03-08	2019-11-13	Academia Sinica	Verfahren zur modularen synthese von n-glykanen und anordnungen davon
WO2017161116A1 (en)	2016-03-17	2017-09-21	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
AU2017241925B2 (en)	2016-03-28	2022-01-13	Ichor Medical Systems, Inc.	Method and apparatus for delivery of therapeutic agents
US10358463B2 (en)	2016-04-05	2019-07-23	Bristol-Myers Squibb Company	Immunomodulators
CA3020312A1 (en)	2016-04-06	2017-10-12	Greenlight Biosciences, Inc.	Cell-free production of ribonucleic acid
US10596321B2 (en)	2016-04-08	2020-03-24	Allergan, Inc.	Aspiration and injection device
KR20230119259A (ko)	2016-04-15	2023-08-16	이뮤넥스트, 인크.	항-인간 vista 항체 및 이의 용도
EP3445385A4 (de)	2016-04-18	2019-11-20	The Trustees of Columbia University in the City of New York	An der progression nichtalkoholischer steatohepatitis (nash) beteiligte therapeutische ziele
US12297266B2 (en)	2016-04-18	2025-05-13	Celldex Therapeutics, Inc.	Agonistic antibodies that bind human CD40 and uses thereof
JOP20170091B1 (ar)	2016-04-19	2021-08-17	Amgen Res Munich Gmbh	إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
CA3019588A1 (en)	2016-04-20	2017-10-26	Merck Sharp & Dohme Corp.	Cmv neutralizing antigen binding proteins
SI3445850T1 (sl)	2016-04-22	2021-12-31	BioNTech SE	Postopki za zagotavljanje enoverižne RNA
EP3932453B1 (de) *	2016-04-29	2025-11-05	Altaviz LLC	Selbständig energieversorgte spritze
JP7422480B2 (ja)	2016-05-04	2024-01-26	アムジエン・インコーポレーテツド	制御性ｔ細胞の増殖のためのインターロイキン－２変異タンパク質
MX392069B (es)	2016-05-09	2025-03-21	Bristol Myers Squibb Co	Anticuerpos del ligando similar al factor de necrosis tumoral 1a (tl1a) y usos de los mismos.
TW201802121A (zh)	2016-05-25	2018-01-16	諾華公司	抗因子XI/XIa抗體之逆轉結合劑及其用途
EA201892385A1 (ru)	2016-06-03	2019-06-28	Санофи Пастер Инк.	Модификация сконструированных полипептидов гемагглютинина вируса гриппа
US10105449B2 (en)	2016-06-07	2018-10-23	Massachusetts Institute Of Technology	Drug delivery polymers and uses thereof
WO2017214269A1 (en)	2016-06-08	2017-12-14	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
IL315266A (en)	2016-06-14	2024-10-01	Merck Sharp ַ& Dohme Llc	Anti-coagulation factor xi antibodies
WO2017218704A1 (en)	2016-06-14	2017-12-21	Modernatx, Inc.	Stabilized formulations of lipid nanoparticles
US20180002417A1 (en)	2016-06-15	2018-01-04	Celimmune Llc	Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
GB201610599D0 (en)	2016-06-17	2016-08-03	Glaxosmithkline Biologicals Sa	Immunogenic Composition
US10328205B2 (en) *	2016-07-07	2019-06-25	Shl Medical Ag	Drug delivery device with pneumatic power pack
CN109757103B (zh)	2016-07-14	2024-01-02	百时美施贵宝公司	针对tim3的抗体及其用途
WO2018018082A1 (en)	2016-07-26	2018-02-01	The Australian National University	Immunostimulatory compositions and uses therefor
US20180028755A1 (en) *	2016-07-28	2018-02-01	Portal Instruments, Inc.	Connected health platform including needle-free injector system
NL2017267B1 (en)	2016-07-29	2018-02-01	Aduro Biotech Holdings Europe B V	Anti-pd-1 antibodies
NL2017270B1 (en)	2016-08-02	2018-02-09	Aduro Biotech Holdings Europe B V	New anti-hCTLA-4 antibodies
WO2018027042A1 (en)	2016-08-03	2018-02-08	Bio-Techne Corporation	Identification of vsig3/vista as a novel immune checkpoint and use thereof for immunotherapy
CA3031797A1 (en)	2016-08-05	2018-02-08	Sanofi Pasteur, Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
NL2017294B1 (en)	2016-08-05	2018-02-14	Univ Erasmus Med Ct Rotterdam	Natural cryptic exon removal by pairs of antisense oligonucleotides.
CA3031799A1 (en)	2016-08-05	2018-02-08	Sanofi Pasteur, Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
CN109641911B (zh)	2016-08-19	2023-02-21	百时美施贵宝公司	seco-环丙吡咯并吲哚化合物和其抗体-药物缀合物以及制备和使用方法
CA3034057A1 (en)	2016-08-22	2018-03-01	CHO Pharma Inc.	Antibodies, binding fragments, and methods of use
WO2018035710A1 (en)	2016-08-23	2018-03-01	Akeso Biopharma, Inc.	Anti-ctla4 antibodies
US10981976B2 (en)	2016-08-31	2021-04-20	University Of Rochester	Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
JOP20190055A1 (ar)	2016-09-26	2019-03-24	Merck Sharp & Dohme	أجسام مضادة ضد cd27
EP3305781A1 (de)	2016-10-07	2018-04-11	Deutsches Krebsforschungszentrum	Chemische substanzen welche die enzymatische aktivität der humanen kallikrein-related peptidase 6 (klk6) hemmen.
MX2019004371A (es)	2016-10-13	2019-11-18	Massachusetts Inst Technology	Anticuerpos que se unen a la proteina de envoltura del virus zika y usos de los mismos.
CN110352073A (zh)	2016-10-28	2019-10-18	机敏医药股份有限公司	针对timp-2的抗体用于改善肾功能的用途
KR102526034B1 (ko)	2016-11-07	2023-04-25	브리스톨-마이어스 스큅 컴퍼니	면역조정제
US11583504B2 (en)	2016-11-08	2023-02-21	Modernatx, Inc.	Stabilized formulations of lipid nanoparticles
WO2018089829A1 (en)	2016-11-10	2018-05-17	Fortis Therapeutics, Inc.	Cd46-specific effector cells and uses thereof
CA3043277A1 (en)	2016-11-11	2018-05-17	The Regents Of The University Of California	Anti-cd46 antibodies and methods of use
AU2017361856A1 (en)	2016-11-18	2019-05-23	Neurovive Pharmaceutical Ab	Use of sanglifehrin macrocyclic analogues as anticancer compounds
WO2018106738A1 (en)	2016-12-05	2018-06-14	Massachusetts Institute Of Technology	Brush-arm star polymers, conjugates and particles, and uses thereof
MX2019007161A (es)	2016-12-21	2020-02-12	Mereo Biopharma 3 Ltd	Uso de anticuerpos anti-esclerostina en el tratamiento de osteogenesis imperfecta.
US10961305B2 (en)	2016-12-21	2021-03-30	Mereo Biopharma 3 Limited	Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
EP3558420B1 (de)	2016-12-23	2024-09-18	Kaleo, Inc.	Medikamentenabgabevorrichtung und verfahren zur abgabe von arzneimitteln an säuglinge und kinder
AU2017383232B2 (en)	2016-12-23	2024-09-12	Novartis Ag	Factor XI antibodies and methods of use
IL267689B2 (en)	2016-12-31	2025-05-01	Bioxcel Therapeutics Inc	Use of sublingual dexmedetomidine for the treatment of agitation
RU2769769C2 (ru)	2017-01-05	2022-04-05	Кахр Медикал Лтд.	СЛИТЫЙ БЕЛОК SIRPα-4-1BBL И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ
CN110536693B (zh)	2017-01-05	2023-12-22	卡尔医学有限公司	Pd1-41bbl融合蛋白及使用其的方法
TW201833140A (zh)	2017-01-09	2018-09-16	美商莫瑞麥克製藥公司	抗fgfr抗體及使用方法
AU2018210313A1 (en)	2017-01-17	2019-06-20	Kaleo, Inc.	Medicament delivery devices with wireless connectivity and event detection
US11377497B2 (en)	2017-01-23	2022-07-05	Suzhou Alphamab Co., Ltd.	PD-L1 binding polypeptide or composite
WO2018140510A1 (en)	2017-01-25	2018-08-02	Biogen Ma Inc.	Compositions and methods for treatment of stroke and other cns disorders
SMT202500367T1 (it)	2017-02-02	2025-11-10	Amgen Res Munich Gmbh	Composizione farmaceutica a basso ph comprendente costrutti di anticorpo che reclutano le cellule t
GB2559553B (en) *	2017-02-06	2021-10-13	Consort Medical Plc	A medicament delivery device
GB201702144D0 (en)	2017-02-09	2017-03-29	Annexin Pharmaceuticals Ab	Therapeutic compositions
JP2020507632A (ja)	2017-02-10	2020-03-12	マウントタムセラピューティクス, インコーポレイテッドMount Tam Therapeutics, Inc.	ラパマイシン類似体
CA3051839A1 (en)	2017-02-17	2018-08-23	Bristol-Myers Squibb Company	Antibodies to alpha-synuclein and uses thereof
GB201703876D0 (en)	2017-03-10	2017-04-26	Berlin-Chemie Ag	Pharmaceutical combinations
CA3055653A1 (en)	2017-03-15	2018-09-20	Modernatx, Inc.	Lipid nanoparticle formulation
EP4186888B1 (de)	2017-03-15	2025-11-26	ModernaTX, Inc.	Verbindung und zusammensetzungen zur intrazellulären verabreichung von therapeutischen wirkstoffen
US11555031B2 (en)	2017-03-20	2023-01-17	The Broad Institute, Inc.	Compounds and methods for regulating insulin secretion
USD867582S1 (en)	2017-03-24	2019-11-19	Allergan, Inc.	Syringe device
CA3058198A1 (en)	2017-04-05	2018-10-11	The Broad Institute, Inc.	Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
TWI788340B (zh)	2017-04-07	2023-01-01	美商必治妥美雅史谷比公司	抗icos促效劑抗體及其用途
TWI796329B (zh)	2017-04-07	2023-03-21	美商默沙東有限責任公司	抗－ilt4抗體及抗原結合片段
KR102702926B1 (ko)	2017-04-13	2024-09-06	사이로파 비.브이.	항-sirp 알파 항체
CN110573492A (zh)	2017-04-25	2019-12-13	阿米库斯治疗学公司	用于预防和/或治疗中枢神经系统退行性失调和/或溶酶体贮积失调的新颖组合物
UY37726A (es)	2017-05-05	2018-11-30	Amgen Inc	Composición farmacéutica que comprende constructos de anticuerpos biespecíficos para almacenamiento y administración mejorados
EP3621649A2 (de)	2017-05-10	2020-03-18	Albajuna Therapeutics, S.L.	Fc-fusionsproteinderivate mit hoher dualer hiv-antiviraler und immunmodulatorischer aktivität
EP3625251A1 (de)	2017-05-15	2020-03-25	University Of Rochester	Breit neutralisierende monoklonale anti-influenza-antikörper und verwendungen davon
US20200299400A1 (en)	2017-05-25	2020-09-24	Bristol-Myers Squibb Company	Antibodies comprising modified heavy constant regions
WO2018232120A1 (en)	2017-06-14	2018-12-20	Modernatx, Inc.	Compounds and compositions for intracellular delivery of agents
MX2019015524A (es)	2017-06-23	2020-09-10	Univ Maryland	Composiciones inmunogenicas.
JP2020524527A (ja)	2017-06-23	2020-08-20	スージョウボジュホワバイオメディカルデクノロジーカンパニーリミテッドＳｕｚｈｏｕＢｏｊｕｈｕａＢｉｏｍｅｄｉｃａｌＴｅｃｈｎｏｌｏｇｙＣｏ．Ｌｔｄ	ヒト腫瘍幹細胞をターゲティングするモノクローナル抗体及びその使用
EP3642220A1 (de)	2017-06-23	2020-04-29	Bristol-Myers Squibb Company	Immunmodulatoren als antagonisten von pd-1
WO2019013789A1 (en)	2017-07-12	2019-01-17	Curza Global, Llc	ANTIMICROBIAL COMPOUNDS
WO2019013790A1 (en)	2017-07-12	2019-01-17	Curza Global, Llc	ANTIMICROBIAL COMPOUNDS AND USES THEREOF
GB201711635D0 (en)	2017-07-19	2017-08-30	Glaxosmithkline Biologicals Sa	Immunogenic composition
AU2018322475A1 (en)	2017-08-22	2020-03-05	Biogen Ma Inc.	Pharmaceutical compositions and dosage regimens containing anti-alpha(v)beta(6) antibodies
GB2584009B (en)	2017-08-28	2022-03-23	Revagenix Inc	Aminoglycosides and uses thereof
JP2020531041A (ja)	2017-08-28	2020-11-05	上海易楽生物技術有限公司	ポリペプチドとポリペプチドに結合される抗体
EP3675817A1 (de)	2017-08-31	2020-07-08	Modernatx, Inc.	Verfahren zur herstellung von lipidnanopartikeln
CN111051332B (zh)	2017-10-03	2024-09-06	百时美施贵宝公司	免疫调节剂
EP3692061A1 (de)	2017-10-04	2020-08-12	Amgen Inc.	Transthyretinimmunoglobulinfusionen
EP3694552A1 (de)	2017-10-10	2020-08-19	Tilos Therapeutics, Inc.	Anti-lap-antikörper und verwendungen davon
KR102894284B1 (ko)	2017-10-11	2025-12-03	그린라이트 바이오사이언시스, 아이엔씨.	뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물
US12441998B2 (en)	2017-10-12	2025-10-14	The Trustees Of Columbia University In The City Of New York	SLC2A1 lncRNA as a biologic and related treatments and methods
WO2019080883A1 (en)	2017-10-26	2019-05-02	Immuneonco Biopharmaceuticals (Shanghai) Co., Ltd.	NOVEL RECOMBINANT FUSION PROTEINS, PREPARATION THEREOF AND USE THEREOF
KR20240171186A (ko)	2017-10-26	2024-12-06	다케다 야쿠힌 고교 가부시키가이샤	글루코세레브로시다제 및 이소파고민을 포함하는 제제
JP2021501801A (ja)	2017-11-01	2021-01-21	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	癌の処置に用いるための免疫刺激アゴニスト抗体
CN111712518B (zh)	2017-11-17	2025-03-25	默沙东有限责任公司	对免疫球蛋白样转录物3(ilt3)具有特异性的抗体及其用途
WO2019109079A1 (en)	2017-12-01	2019-06-06	North Carolina State University	Fibrin particles and methods of making the same
AU2018383679B2 (en)	2017-12-11	2025-10-09	Amgen Inc.	Continuous manufacturing process for bispecific antibody products
EP3727333A1 (de) *	2017-12-21	2020-10-28	Taiwan Liposome Company Ltd	Triptanzusammensetzungen mit verzögerter freisetzung und verfahren zur herstellung davon auf subdermalem weg oder dergleichen
SG11202004971YA (en)	2017-12-21	2020-06-29	Gliapharm Sa	Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
US20200339591A1 (en)	2017-12-21	2020-10-29	Gliapharm Sa	Compositions and methods of treatment for neurological disorders comprising a dementia
GB201721576D0 (en)	2017-12-21	2018-02-07	Glaxosmithkline Biologicals Sa	Hla antigens and glycoconjugates thereof
GB201721582D0 (en)	2017-12-21	2018-02-07	Glaxosmithkline Biologicals Sa	S aureus antigens and immunogenic compositions
CN111788227B (zh)	2017-12-27	2025-02-25	百时美施贵宝公司	抗cd40抗体及其用途
TW201940518A (zh)	2017-12-29	2019-10-16	美商安進公司	針對ｍｕｃ１７和ｃｄ３之雙特異性抗體構建體
US12247060B2 (en)	2018-01-09	2025-03-11	Marengo Therapeutics, Inc.	Calreticulin binding constructs and engineered T cells for the treatment of diseases
EP3737700A1 (de)	2018-01-12	2020-11-18	Bristol-Myers Squibb Company	Antikörper gegen tim3 und verwendungen davon
WO2019148412A1 (en)	2018-02-01	2019-08-08	Merck Sharp & Dohme Corp.	Anti-pd-1/lag3 bispecific antibodies
US11787857B2 (en)	2018-02-02	2023-10-17	Bio-Techne Corporation	Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using
BR112020014978A2 (pt)	2018-02-05	2020-12-22	Sanofi Pasteur, Inc.	Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
EP3749357A4 (de)	2018-02-05	2022-04-20	Sanofi Pasteur, Inc.	Polyvalente pneumokokken-polysaccharid-proteinkonjugatzusammensetzung
KR101859735B1 (ko) *	2018-02-07	2018-05-21	주식회사 피테크	무통 주사 장치
MA51747A (fr)	2018-02-08	2020-12-16	Amgen Inc	Formulation d'anticorps pharmaceutique à ph faible
NL2020520B1 (en)	2018-03-02	2019-09-12	Labo Bio Medical Invest B V	Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
EP3765517A1 (de)	2018-03-14	2021-01-20	Elstar Therapeutics, Inc.	An calreticulin bindende multifunktionsmoleküle und ihre verwendungen
KR20200143391A (ko)	2018-03-15	2020-12-23	비온테크 알엔에이 파마슈티컬스 게엠베하	5'-캡-트리뉴클레오티드- 또는 고차의 올리고뉴클레오티드 화합물 및 이들의 rna 안정화, 단백질 발현 및 치료에서의 사용
EP3768715A1 (de)	2018-03-23	2021-01-27	Bristol-Myers Squibb Company	Antikörper gegen mica und/or micb und deren verwendungen
CN112165957A (zh)	2018-03-26	2021-01-01	上海易乐生物技术有限公司	proBDNF调节剂在B细胞相关疾病中的用途
WO2019195126A1 (en)	2018-04-02	2019-10-10	Bristol-Myers Squibb Company	Anti-trem-1 antibodies and uses thereof
WO2019194858A1 (en)	2018-04-03	2019-10-10	Achaogen, Inc.	Modular synthesis of aminoglycosides
PT3773713T (pt)	2018-04-06	2025-07-29	Regeneron Pharma	Anticorpo agonista do recetor de leptina para usar no aumento da massa óssea num sujeito que sofre de disfunção metabólica ou de hipoleptinemia
US20210169969A1 (en)	2018-04-06	2021-06-10	Leonardus H.T. Van Der Ploeg	Compositions for treating kidney disease
BR112020020826A2 (pt)	2018-04-12	2021-01-19	Bristol-Myers Squibb Company	Terapia de combinação anticâncer com anticorpo antagonista de cd73 e anticorpo antagonista do eixo pd-1/pd-l1
CA3097369A1 (en)	2018-04-17	2019-10-24	Celldex Therapeutics, Inc.	Anti-cd27 and anti-pd-l1 antibodies and bispecific constructs
US12139480B2 (en)	2018-04-20	2024-11-12	Iomx Therapeutics Ag	5-thiazolecarboxamide kinase inhibitor and uses thereof
KR102107578B1 (ko) *	2018-05-02	2020-05-07	주식회사 피테크	무통 주사기용 약액주입 제어장치 및 이를 구비하는 무통 주사기
KR102104080B1 (ko) *	2018-05-02	2020-04-23	주식회사 피테크	무통 주사기용 음파발진장치 및 이를 구비하는 무통 주사기
KR101907552B1 (ko)	2018-05-03	2018-10-12	주식회사 피테크	무바늘 무통 주사 장치
CA3096703A1 (en)	2018-05-03	2019-11-07	University Of Rochester	Anti-influenza neuraminidase monoclonal antibodies and uses thereof
CA3101364A1 (en)	2018-05-25	2019-11-28	Primmune Therapeutics, Inc.	Tlr7 agonists
CN119080931A (zh)	2018-06-04	2024-12-06	马萨诸塞州渤健公司	具有降低的效应功能的抗vla-4抗体
US11951286B2 (en) *	2018-06-12	2024-04-09	Banza Stamping Industry Corp.	Automatic injection device for fluid
GB201809746D0 (en)	2018-06-14	2018-08-01	Berlin Chemie Ag	Pharmaceutical combinations
BR112020025987A2 (pt)	2018-06-21	2021-03-23	Yumanity Therapeutics, Inc.	composições e métodos para tratamento e prevenção de distúrbios neurológicos
EP3810132A4 (de)	2018-06-25	2022-06-22	Dana-Farber Cancer Institute, Inc.	Kinaseinhibitoren der taire und ihre verwendungen
BR112020026672A2 (pt)	2018-06-27	2021-03-30	Bioxcel Therapeutics, Inc.	Formulações de filme contendo dexmedetomidina e métodos para produzi-las
CA3105448A1 (en)	2018-07-03	2020-01-09	Elstar Therapeutics, Inc.	Anti-tcr antibody molecules and uses thereof
KR102945860B1 (ko)	2018-07-11	2026-03-31	카 메디컬 리미티드	SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
US11929160B2 (en)	2018-07-16	2024-03-12	Kaleo, Inc.	Medicament delivery devices with wireless connectivity and compliance detection
CA3107186A1 (en)	2018-07-30	2020-02-06	Amgen Research (Munich) Gmbh	Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
CA3105729A1 (en)	2018-07-31	2020-02-06	Amgen Research (Munich) Gmbh	Dosing regimen for bcma-cd3 bispecific antibodies
SG11202013248YA (en)	2018-07-31	2021-02-25	Amgen Inc	Pharmaceutical formulations of masked antibodies
WO2020025792A1 (en)	2018-08-03	2020-02-06	Amgen Research (Munich) Gmbh	Antibody constructs for cldn18.2 and cd3
JP7193058B2 (ja)	2018-08-08	2022-12-20	イミューンオンコバイオファーマシューティカルズ（シャンハイ）インコーポレイテッド	Ｃｄ４７およびｈｅｒ２を標的とする組換え二機能性タンパク質
WO2020047251A1 (en)	2018-08-29	2020-03-05	President And Fellows Of Harvard College	O-glcnac transferase inhibitors and uses thereof
WO2020049208A1 (es)	2018-09-09	2020-03-12	Fundacio Privada Institut De Recerca De La Sida - Caixa	Aurora cinasa como diana para tratar, prevenir o curar una infección por vih o sida
EP3853252A1 (de)	2018-09-18	2021-07-28	Merrimack Pharmaceuticals, Inc.	Anti-tnfr2-antikörper und verwendungen davon
WO2020061367A1 (en)	2018-09-19	2020-03-26	Modernatx, Inc.	Compounds and compositions for intracellular delivery of therapeutic agents
WO2020061457A1 (en)	2018-09-20	2020-03-26	Modernatx, Inc.	Preparation of lipid nanoparticles and methods of administration thereof
KR102199724B1 (ko) *	2018-10-05	2021-01-07	주식회사 피테크	무바늘 무통 주사 장치
CN113164780A (zh)	2018-10-10	2021-07-23	泰洛斯治疗公司	抗lap抗体变体及其用途
JP7644706B2 (ja)	2018-10-11	2025-03-12	アムジエン・インコーポレーテツド	二重特異性抗体コンストラクトの下流プロセシング
DK3643713T3 (da)	2018-10-23	2025-11-03	Iomx Therapeutics Ag	Heterocykliske kinaseinhibitorer og deres anvendelse
WO2020084005A1 (en)	2018-10-23	2020-04-30	Myelopro Diagnostics And Research Gmbh	Compounds targeting mutant calreticulin
US11160791B2 (en)	2018-11-01	2021-11-02	Medefil, Inc.	Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CA3117945A1 (en)	2018-11-09	2020-05-14	University Of Massachusetts	Anti-cfae antibodies and methods of use
CN113316590B (zh)	2018-11-16	2025-02-28	百时美施贵宝公司	抗nkg2a抗体及其用途
EP3887397A1 (de)	2018-11-28	2021-10-06	Bristol-Myers Squibb Company	Antikörper mit modifizierten schweren konstanten regionen
WO2020113063A1 (en)	2018-11-30	2020-06-04	Aleta Biotherapeutics Inc.	Single domain antibodies against cll-1
WO2020118011A1 (en)	2018-12-06	2020-06-11	Alexion Pharmaceuticals, Inc.	Anti-alk2 antibodies and uses thereof
KR20210104744A (ko)	2018-12-18	2021-08-25	리제너론 파마슈티칼스 인코포레이티드	렙틴 수용체, gdf8 및 액티빈 a에 대한 길항제를 사용하여 체중 및 제지방 근육량을 향상시키기 위한 조성물 및 방법
TW202039554A (zh)	2018-12-19	2020-11-01	瑞士商諾華公司	抗ＴＮＦ－α抗體
WO2020132378A2 (en)	2018-12-22	2020-06-25	Gliapharm Sa	Compositions and methods of treatment for neurological disorders comprising depression
US12281126B2 (en)	2018-12-28	2025-04-22	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 and uses thereof
EP3902584A4 (de)	2018-12-29	2022-09-07	Kaleo, Inc.	Vorrichtungen und verfahren zur abgabe von substanzen in einer vorgefüllten spritze
WO2020144535A1 (en)	2019-01-08	2020-07-16	Aduro Biotech Holdings, Europe B.V.	Methods and compositions for treatment of multiple myeloma
AU2020209167B2 (en)	2019-01-16	2025-09-04	Curza Global, Llc	Antimicrobial compounds and methods
AU2020209170B2 (en)	2019-01-16	2025-09-04	Curza Global, Llc	Antimicrobial compounds and methods
CN109762067B (zh)	2019-01-17	2020-02-28	北京天广实生物技术股份有限公司	结合人Claudin 18.2的抗体及其用途
BR112021014276A2 (pt)	2019-01-22	2021-09-28	Genentech, Inc.	Anticorpos iga isolados, moléculas de fusão igg-iga isoladas, ácido nucleico isolado, célula hospedeira, método para produzir um anticorpo, para tratar um indivíduo, para aumentar a expressão de dímeros, trímeros ou tetrâmeros, para aumentar a produção de polímeros, para aumentar a produção de dímeros, para aumentar a produção de um polímero, para diminuir a produção de polímeros, para aumentar a expressão transitória de um anticorpo, para expressar dímeros de moléculas de fusão, para expressar dímeros, trímeros ou tetrâmeros, para purificar um anticorpo, para purificar um estado oligomérico de um anticorpo, composição farmacêutica e uso do anticorpo
IL285067B2 (en)	2019-01-22	2025-02-01	Aeovian Pharmaceuticals Inc	MTORC Modulators and Their Uses
CN113396162B (zh)	2019-01-22	2024-08-16	百时美施贵宝公司	抗IL-7Rα亚基的抗体及其用途
CN118697900A (zh)	2019-01-31	2024-09-27	摩登纳特斯有限公司	制备脂质纳米颗粒的方法
WO2020168466A1 (en)	2019-02-19	2020-08-27	Stemirna Therapeutics Co., Ltd.	Modified nucleoside and synthetic methods thereof
CN119039441A (zh)	2019-02-21	2024-11-29	马伦戈治疗公司	与nkp30结合的抗体分子及其用途
GB2599228B (en)	2019-02-21	2024-02-07	Marengo Therapeutics Inc	Multifunctional molecules that bind to T cell related cancer cells and uses thereof
CA3131953A1 (en)	2019-03-01	2020-09-10	Merrimack Pharmaceuticals, Inc.	Anti-tnfr2 antibodies and uses thereof
US10570210B1 (en)	2019-03-04	2020-02-25	Beijing Mabworks Biotech Co.Ltd	Antibodies binding CD40 and uses thereof
MA55298A (fr)	2019-03-11	2022-01-19	Biogen Ma Inc	Compositions pharmaceutiques contenant des anticorps anti-lingo-1
US11230593B2 (en)	2019-03-25	2022-01-25	Visterra, Inc.	Compositions and methods for treating and preventing influenza
KR20220005471A (ko)	2019-04-08	2022-01-13	바이오젠 엠에이 인코포레이티드	항-인테그린 항체 및 이의 용도
US12404331B2 (en)	2019-04-19	2025-09-02	Tcrcure Biopharma Corp.	Anti-PD-1 antibodies and uses thereof
KR20220010535A (ko)	2019-05-21	2022-01-25	브리스톨-마이어스 스큅 컴퍼니	면역조정제
EP3983015A1 (de)	2019-06-11	2022-04-20	Regeneron Pharmaceuticals, Inc.	Pcrv-bindende anti-pcrv-antikörper, zusammensetzungen mit anti-pcrv-antikörpern und verfahren zu deren verwendung
MX2021014644A (es)	2019-06-13	2022-04-06	Amgen Inc	Control de perfusion basado en biomasa automatizado en la fabricacion de productos biologicos.
EP3997112A1 (de)	2019-07-08	2022-05-18	Amgen, Inc	Multispezifische transthyretin-immunglobulin-fusionen
US20220267409A1 (en)	2019-07-11	2022-08-25	Kahr Medical Ltd.	Heterodimers and methods of use thereof
CN114174536B (zh)	2019-07-15	2026-03-27	百时美施贵宝公司	抗trem-1抗体及其用途
WO2021011681A1 (en)	2019-07-15	2021-01-21	Bristol-Myers Squibb Company	Antibodies against human trem-1 and uses thereof
CA3145345A1 (en)	2019-07-15	2021-01-21	Intervet International B.V.	Caninized antibodies against canine ctla-4
WO2021009188A1 (en)	2019-07-15	2021-01-21	Intervet International B.V.	Caninized antibodies to human and canine ctla-4
BR112022000992A2 (pt)	2019-07-19	2022-06-14	Arx Llc	Regimes de tratamento de dexmedetomidina não sedantes
PH12022550110A1 (en)	2019-07-31	2022-12-12	Sk Bioscience Co Ltd	Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US20220280639A1 (en)	2019-07-31	2022-09-08	Modernatx, Inc.	Compositions and methods for delivery of rna interference agents to immune cells
CA3145580A1 (en)	2019-08-09	2021-02-18	Kaleo, Inc.	Devices and methods for delivery of substances within a prefilled syringe
PH12022550326A1 (en)	2019-08-13	2023-03-13	Amgen Inc	Interleukin-2 muteins for the expansion of t-regulatory cells
AU2020346062A1 (en)	2019-09-13	2022-03-24	Rutgers, The State University Of New Jersey	AAV-compatible laminin-linker polymerization proteins
KR20220088868A (ko)	2019-10-30	2022-06-28	브리스톨-마이어스 스큅 컴퍼니	면역조정제
LT3819007T (lt)	2019-11-11	2024-10-10	Amgen Research (Munich) Gmbh	Dozavimo režimas, skirtas anti-bcma agentams
US20220396599A1 (en)	2019-11-13	2022-12-15	Amgen Inc.	Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules
CA3158103A1 (en)	2019-11-13	2021-05-20	Curza Global, Llc	Antimicrobial compounds and methods
WO2021102143A1 (en)	2019-11-19	2021-05-27	Bristol-Myers Squibb Company	Macrocyclic peptides as pd-l1 inhibitors and immunomodulators for the treatment of cancer and infectious diseases
WO2021119467A1 (en)	2019-12-11	2021-06-17	Visterra, Inc.	Compositions and methods for treating and preventing influenza
IL293471A (en)	2019-12-17	2022-08-01	Amgen Inc	Dual interleukin-2 / tnf receptor agonist for use in medicine
IL293640A (en)	2019-12-20	2022-08-01	Amgen Inc	CD40 antagonistic mesothelin-targeted multispecific antibody constructs for the treatment of solid tumors
CN121108343A (zh)	2019-12-20	2025-12-12	英特维特国际股份有限公司	犬白介素-4受体α抗体
MX2022007676A (es)	2019-12-20	2022-07-19	Intervet Int Bv	Anticuerpos caninizados biespecificos para tratar dermatitis atopica.
WO2021127500A1 (en)	2019-12-20	2021-06-24	Momenta Pharmaceuticals, Inc.	Antibodies against integrin alpha 11 beta 1
WO2021136308A1 (en)	2020-01-03	2021-07-08	Biosion Inc.	Antibodies binding bcma and uses thereof
AU2020416273A1 (en)	2020-01-03	2022-07-28	Marengo Therapeutics, Inc.	Anti-TCR antibody molecules and uses thereof
CN114929714B (zh)	2020-01-06	2024-05-31	百时美施贵宝公司	用于治疗癌症和感染性疾病的作为pd-l1抑制剂和免疫调节剂的大环肽
EP4087857B1 (de)	2020-01-06	2023-11-01	Bristol-Myers Squibb Company	Immunmodulatoren
CN110818795B (zh)	2020-01-10	2020-04-24	上海复宏汉霖生物技术股份有限公司	抗tigit抗体和使用方法
US20230093169A1 (en)	2020-01-22	2023-03-23	Amgen Research (Munch) Gmbh	Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
CA3169669A1 (en)	2020-01-31	2021-08-05	Modernatx, Inc.	Methods of preparing lipid nanoparticles
BR112022017174A2 (pt)	2020-02-27	2022-10-18	Chia Tai Tianqing Pharmaceutical Group Co Ltd	Anticorpo monoclonal isolado, ou uma porção de ligação ao antígeno do mesmo, nucleotídeo, vetor de expressão, célula hospedeira, composição farmacêutica e métodos de tratamento de uma doença alérgica e de um tumor
US11642407B2 (en)	2020-02-28	2023-05-09	Massachusetts Institute Of Technology	Identification of variable influenza residues and uses thereof
CN115485302A (zh)	2020-03-09	2022-12-16	百时美施贵宝公司	具有增强的激动剂活性的针对cd40的抗体
KR20220155332A (ko)	2020-03-16	2022-11-22	브리스톨-마이어스 스큅 컴퍼니	면역조정제
WO2021188851A1 (en)	2020-03-19	2021-09-23	Amgen Inc.	Antibodies against mucin 17 and uses thereof
WO2021195089A1 (en)	2020-03-23	2021-09-30	Sorrento Therapeutics, Inc.	Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, compositions and methods of use thereof
KR20220161407A (ko)	2020-03-30	2022-12-06	브리스톨-마이어스 스큅 컴퍼니	면역조정제
WO2021202235A1 (en)	2020-04-01	2021-10-07	University Of Rochester	Monoclonal antibodies against the hemagglutinin (ha) and neuraminidase (na) of influenza h3n2 viruses
US20230272056A1 (en)	2020-04-09	2023-08-31	Merck Sharp & Dohme Llc	Affinity matured anti-lap antibodies and uses thereof
EP3901151B1 (de)	2020-04-21	2026-04-01	iOmx Therapeutics AG	Halogenierte heteroaryl- und andere heterocyclische kinaseinhibitoren und verwendungen davon
EP4139341A1 (de)	2020-04-21	2023-03-01	Regeneron Pharmaceuticals, Inc.	Il-2-varianten mit reduzierter bindung an il-2-rezeptor-alpha und verwendungen davon
MX2021015024A (es)	2020-04-28	2022-01-18	Univ Rockefeller	Anticuerpos anti-sars-cov-2 ampliamente neutralizantes y métodos de uso de los mismos.
AU2021262482A1 (en)	2020-04-28	2023-01-05	Iomx Therapeutics Ag	Bicyclic kinase inhibitors and uses thereof
CN115461080A (zh)	2020-04-29	2022-12-09	安进公司	药物配制品
CA3173706A1 (en)	2020-04-29	2021-11-04	Twinkle R. Christian	Pharmaceutical formulation
EP4143227A2 (de)	2020-04-30	2023-03-08	Sairopa B.V.	Anti-cd103 antikörper
WO2021226460A1 (en)	2020-05-08	2021-11-11	Bristol-Myers Squibb Company	Immunomodulators
WO2021231729A1 (en)	2020-05-13	2021-11-18	Sanofi	Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
US20230192867A1 (en)	2020-05-15	2023-06-22	Bristol-Myers Squibb Company	Antibodies to garp
CA3183756A1 (en)	2020-05-19	2021-11-25	Amgen Inc.	Mageb2 binding constructs
US20230277524A1 (en)	2020-05-22	2023-09-07	Trailhead Biosystems Inc.	Combination therapy for treatment of viral infections
CN111529830B (zh) *	2020-05-22	2024-10-15	江阴市机电技术有限公司	一种启动稳定的给药装置
US20240209085A1 (en)	2020-05-29	2024-06-27	Amgen Inc.	Adverse effects-mitigating administration of a bispecific construct binding to cd33 and cd3
WO2021252708A1 (en)	2020-06-11	2021-12-16	President And Fellows Of Harvard College	Stabilized trioxacarcin antibody drug conjugates and uses thereof
FR3112939B1 (fr)	2020-07-31	2024-01-05	Univ Montpellier	Produit universel de thérapie cellulaire et son utilisation
EP4192511A1 (de)	2020-08-07	2023-06-14	Fortis Therapeutics, Inc.	Gegen cd46 gerichtete immunkonjugate und verfahren zur verwendung davon
EP4200333A1 (de)	2020-08-24	2023-06-28	Amgen Inc.	Pharmazeutische formulierung mit einem biss, bispezifischem antikörper und methionin
WO2022061219A1 (en) *	2020-09-21	2022-03-24	Boston Scientific Scimed, Inc.	Fluid pressure indicators for medical devices
CN116322735A (zh)	2020-10-02	2023-06-23	百时美施贵宝公司	大环肽硼酸盐免疫调节剂
US20230374073A1 (en)	2020-10-08	2023-11-23	Bristol-Myers Squibb Company	Dimeric milla immunomodulators
KR20230084211A (ko)	2020-10-09	2023-06-12	브리스톨-마이어스 스큅 컴퍼니	마크로시클릭 면역조정제
US20220267450A1 (en)	2020-10-14	2022-08-25	Viridian Therapeutics, Inc.	Compositions and methods for treatment of thyroid eye disease
JP2023545182A (ja)	2020-10-15	2023-10-26	インターベットインターナショナルベー．フェー．	イヌインターロイキン－３１受容体アルファに対するイヌ化ラット抗体
EP4238979A4 (de)	2020-10-30	2024-09-25	Xeno-Interface Inc.	Vernetztes beta-strang-peptid
CN117083065A (zh)	2020-10-30	2023-11-17	庆应义塾	肌肉减少症相关疾病等的新颖治疗和预防
TW202227481A (zh)	2020-11-04	2022-07-16	美國洛克菲勒大學	中和抗sars-cov-2抗體
WO2022096704A1 (en)	2020-11-06	2022-05-12	Amgen Inc.	Antigen binding domain with reduced clipping rate
CR20230229A (es)	2020-11-06	2023-09-05	Amgen Res Munich Gmbh	Moléculas de unión a antígeno biespecíficas con múltiples dianas de selectividad aumentada
UY39507A (es)	2020-11-06	2022-03-31	Amgen Res Munich Gmbh	Construcciones polipeptídicas que se unen selectivamente a cldn6 y cd3
TW202225188A (zh)	2020-11-06	2022-07-01	德商安美基研究（慕尼黑）公司	與ｃｄ３結合的多肽構建體
EP4243936A1 (de)	2020-11-10	2023-09-20	Amgen Inc.	Verfahren zur verabreichung eines bcma x cd3-bindenden moleküls
MX2023005386A (es)	2020-11-11	2023-05-23	BioNTech SE	Anticuerpos monoclonales dirigidos contra la proteina de muerte programada-1 y su uso en medicina.
WO2022116877A1 (en)	2020-12-02	2022-06-09	Shanghai Henlius Biotech, Inc.	ANTI-GARP/TGFβ ANTIBODIES AND METHODS OF USE
TW202237068A (zh)	2020-12-09	2022-10-01	美商建南德克公司	製備脂質奈米顆粒的高通量方法及其用途
DE102020134181A1 (de)	2020-12-18	2022-06-23	Henke-Sass, Wolf Gmbh	Vorrichtung zum Applizieren eines Fluids
CN114685669A (zh)	2020-12-30	2022-07-01	和铂医药(苏州)有限公司	结合trop2的抗体及其用途
WO2022155324A1 (en)	2021-01-15	2022-07-21	The Rockefeller University	Neutralizing anti-sars-cov-2 antibodies
US12268847B1 (en)	2021-02-10	2025-04-08	Kaleo, Inc.	Devices and methods for delivery of substances within a medicament container
US12433847B2 (en)	2021-03-09	2025-10-07	Massachusetts Institute Of Technology	Branched poly(-amino esters) for the delivery of nucleic acids
JP2024510207A (ja)	2021-03-12	2024-03-06	ブリストル－マイヤーズスクイブカンパニー	Ｋｒａｓ阻害剤
KR20230160321A (ko)	2021-03-24	2023-11-23	브리스톨-마이어스 스큅 컴퍼니	면역조정제
CA3214853A1 (en)	2021-04-09	2022-10-13	Celidex Therapeutics, Inc.	Antibodies against ilt4, bispecific anti-ilt4/pd-l1 antibody and uses thereof
WO2022221284A2 (en)	2021-04-12	2022-10-20	Bristol-Myers Squibb Company	Cyclic peptide immunomodulators
JP2024518369A (ja)	2021-05-06	2024-05-01	アムジェンリサーチ（ミュニック）ゲゼルシャフトミットベシュレンクテルハフツング	増殖性疾患で使用されるｃｄ２０及びｃｄ２２標的化抗原結合分子
EP4334343A2 (de)	2021-05-06	2024-03-13	The Rockefeller University	Neutralisierende anti-sars-cov-2-antikörper und verfahren zur verwendung davon
EP4333805A1 (de)	2021-05-06	2024-03-13	Amgen Inc.	Etelcalcetidformulierungen
JP2024517903A (ja)	2021-05-10	2024-04-23	イッサムリサーチディベロップメントカンパニーオブザヘブライユニバーシティーオブエルサレムリミテッド	神経学的状態を治療するための薬学的組成物
CN117769434A (zh)	2021-05-20	2024-03-26	黛安瑟斯医疗运营公司	与C1s结合的抗体和其用途
AU2022282609A1 (en)	2021-05-26	2023-11-30	Oxford Biotherapeutics Ltd	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
TW202313065A (zh)	2021-05-28	2023-04-01	美商季卡尼醫療公司	用於治療遺傳疾病之化合物
JP2024526072A (ja)	2021-06-09	2024-07-17	ブリストル－マイヤーズスクイブカンパニー	環状ペプチド免疫調節剤
WO2022258792A1 (en)	2021-06-09	2022-12-15	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Novel anti-fibrotic drugs
AU2022304662A1 (en)	2021-06-30	2023-11-23	Amgen Inc.	Method of reconstituting lyophilized formulation
US20240360178A1 (en)	2021-07-12	2024-10-31	Bristol-Myers Squibb Company	Macrocyclic immunomodulators
WO2023004240A1 (en)	2021-07-19	2023-01-26	Bristol-Myers Squibb Company	Macrocylic immunomodulators
AU2022316209A1 (en)	2021-07-20	2024-02-22	Regeneron Pharmaceuticals, Inc.	Butyrophilin-like 2 agents for treating inflammatory disorders
CN113398365B (zh) *	2021-07-21	2022-10-28	南京瑞淇卓越医疗美容诊所有限公司	一种心血管内科用的临床造影注射装置及注射方法
EP4384219A4 (de)	2021-08-10	2025-06-18	Viridian Therapeutics, Inc.	Zusammensetzungen, dosen und verfahren zur behandlung von schilddrüsenaugenkrankheit
CN118176204A (zh)	2021-08-11	2024-06-11	圣诺菲·帕斯图尔公司	截短的流感神经氨酸酶及其使用方法
JP2024532158A (ja)	2021-08-20	2024-09-05	インターベットインターナショナルベー．フェー．	アトピー性皮膚炎を治療するためのホモ二量体融合タンパク質
AU2022329459A1 (en)	2021-08-20	2024-02-29	Intervet International B.V.	Antibodies and igg fusion proteins with an extended half-life
WO2023039108A1 (en)	2021-09-08	2023-03-16	Affinivax, Inc.	Coronavirus vaccine
CN113773401B (zh)	2021-09-15	2023-06-20	宜明昂科生物医药技术（上海）股份有限公司	靶向cd47和pd-l1的重组融合蛋白及其制备和用途
WO2023056240A2 (en)	2021-09-28	2023-04-06	Frontaim Biomedicines, Inc.	Multiple formats of molecular complexes
AU2022361432A1 (en)	2021-10-08	2024-05-23	Sanofi Pasteur Inc.	Multivalent influenza vaccines
CN113956363B (zh)	2021-10-13	2023-03-31	宜明昂科生物医药技术（上海）股份有限公司	靶向cd47和cd24的重组融合蛋白及其制备和用途
CN113754769B (zh)	2021-10-13	2023-06-06	宜明昂科生物医药技术（上海）股份有限公司	靶向cd70的抗体及其制备和用途
CN113831412B (zh)	2021-10-13	2023-06-20	宜明昂科生物医药技术（上海）股份有限公司	靶向cd24的抗体及其制备和用途
AU2022364888A1 (en)	2021-10-14	2024-05-30	Latticon (Suzhou) Biopharmaceuticals Co., Ltd.	Novel antibody-cytokine fusion protein, preparation method therefor and use thereof
KR20240089796A (ko)	2021-10-20	2024-06-20	브리스톨-마이어스 스큅 컴퍼니	면역조정제
US20260070986A1 (en)	2021-11-03	2026-03-12	Affimed Gmbh	Bispecific cd16a binders
IL312515A (en)	2021-11-03	2024-07-01	Affimed Gmbh	Bispecific cd16a binders
AU2022379948A1 (en)	2021-11-05	2024-06-20	Sanofi Pasteur Inc.	Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
WO2023079113A1 (en)	2021-11-05	2023-05-11	Sanofi	Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
WO2023077521A1 (en)	2021-11-08	2023-05-11	Celldex Therapeutics, Inc	Anti-ilt4 and anti-pd-1 bispecific constructs
US20250073346A1 (en)	2021-11-18	2025-03-06	Oxford Bio Therapeutics Ltd	Pharmaceutical combinations
WO2023096904A2 (en)	2021-11-24	2023-06-01	President And Fellows Of Harvard College	C-16 modified trioxacarcins, antibody drug conjugates, and uses thereof
JP2024544009A (ja)	2021-12-03	2024-11-26	ブリストル－マイヤーズスクイブカンパニー	大員環免疫調節剤
US12171779B2 (en)	2021-12-08	2024-12-24	University Of South Florida	Regulated drug delivery via controlled degradable chondroitin sulfate particles
WO2023105281A1 (en)	2021-12-11	2023-06-15	Fundaciò Privada Institut De Recerca De La Sida-Caixa	Soluble tigit recombinant proteins
IL313473A (en)	2021-12-15	2024-08-01	Interius Biotherapeutics Inc	Pseudotyped viral particles, compositions comprising the same, and uses thereof
MX2024007090A (es)	2021-12-16	2024-08-22	Intervet Int Bv	Anticuerpos caninizados para el receptor alfa ii de interleucina-31 canino.
CA3240904A1 (en)	2021-12-16	2023-06-22	Intervet International B.V.	Caninized and felinized antibodies to human ngf
WO2023114889A1 (en)	2021-12-16	2023-06-22	Modernatx, Inc.	Processes for preparing lipid nanoparticles
KR20240122784A (ko)	2021-12-17	2024-08-13	상하이 헨리우스 바이오테크, 인크.	항-ox40 항체 및 사용 방법
KR20240116755A (ko)	2021-12-17	2024-07-30	상하이 헨리우스 바이오테크, 인크.	항-ox40 항체, 다중 특이적 항체 및 이의 사용 방법
US20250084041A1 (en)	2021-12-30	2025-03-13	Curza Global, Llc	Antimicrobial compounds and methods
JPWO2023145735A1 (de)	2022-01-25	2023-08-03
US20250333485A1 (en)	2022-01-27	2025-10-30	The Rockefeller University	Broadly neutralizing anti-sars-cov-2 antibodies targeting the n-terminal domain of the spike protein and methods of use thereof
JP2025503207A (ja)	2022-01-27	2025-01-30	サノフィ・パスツール	修飾されたＶｅｒｏ細胞、及びウイルス産生にこれを使用する方法
AU2023223413A1 (en)	2022-02-24	2024-10-10	Sinomab Bioscience Limited	Bispecific binding proteins against alarmins and uses thereof
CN119522229A (zh)	2022-03-04	2025-02-25	瑞瓦吉尼克斯股份有限公司	广谱氨基糖苷及其用途
EP4494146A1 (de)	2022-03-14	2025-01-22	Sanofi Pasteur, Inc.	Maschinenlernverfahren beim proteinentwurf zur impfstofferzeugung
WO2023173393A1 (zh)	2022-03-18	2023-09-21	北京天广实生物技术股份有限公司	结合b7-h3的抗体及其用途
WO2023175171A1 (en)	2022-03-18	2023-09-21	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Bk polyomavirus antibodies and uses thereof
CA3245762A1 (en)	2022-03-25	2023-09-28	Shanghai Henlius Biologics Co., Ltd.	ANTI-MSLN ANTIBODIES AND METHODS OF USE
US20250250299A1 (en)	2022-03-28	2025-08-07	Bristol-Myers Squibb Company	Macrocyclic immunomodulators
US20250214046A1 (en)	2022-04-01	2025-07-03	Modernatx, Inc.	Cross mixers for lipid nanoparticle production, and methods of operating the same
EP4257132A1 (de)	2022-04-08	2023-10-11	iOmx Therapeutics AG	Sik3-inhibitoren zum behandeln von krankheiten, die gegen death-rezeptor -signaltransduktion resistent sind
EP4257609A1 (de)	2022-04-08	2023-10-11	iOmx Therapeutics AG	Kombinationstherapien basierend auf pd-1-inhibitoren und sik3-inhibitoren
AU2023259350A1 (en)	2022-04-26	2024-10-17	Amgen Inc.	Lyophilization method
EP4522651A1 (de)	2022-05-12	2025-03-19	Amgen Research (Munich) GmbH	Mehrkettige, multitargeting, bispezifische antigenbindende moleküle mit erhöhter selektivität
EP4522654A1 (de)	2022-05-12	2025-03-19	BioNTech SE	Monoklonale antikörper gegen protein mit programmiertem tod-1 und ihre verwendung in der medizin
GB202207263D0 (en)	2022-05-18	2022-06-29	Annexin Pharmaceuticals Ab	Therapeutic compositions
US20260022142A1 (en)	2022-05-20	2026-01-22	Bristol-Myers Squibb Company	Macrocyclic immunomodulators
CN117186238A (zh)	2022-05-31	2023-12-08	宜明昂科生物医药技术（上海）股份有限公司	靶向pd-l1和vegf的重组融合蛋白及其制备和用途
WO2023235380A1 (en)	2022-06-01	2023-12-07	Zikani Therapeutics, Inc.	Macrolides for treating genetic diseases
CN119630676A (zh)	2022-06-10	2025-03-14	百时美施贵宝公司	作为kras抑制剂的吡啶并[4,3-d]嘧啶衍生物
CN119317629A (zh)	2022-06-10	2025-01-14	百时美施贵宝公司	作为kras抑制剂的四氢吡啶并3,4-d嘧啶衍生物
WO2023250513A1 (en)	2022-06-24	2023-12-28	Zikani Therapeutics, Inc.	13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
KR20250057777A (ko)	2022-07-25	2025-04-29	인테리우스 바이오테라퓨틱스, 인코포레이티드	돌연변이된 폴리펩티드, 이를 포함하는 조성물, 및 그 용도(mutated polypeptides, compositions comprising the same, and uses thereof)
WO2024026482A1 (en)	2022-07-29	2024-02-01	Modernatx, Inc.	Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
US20250375389A1 (en)	2022-07-29	2025-12-11	Modernatx, Inc.	Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
WO2024026475A1 (en)	2022-07-29	2024-02-01	Modernatx, Inc.	Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
JP2025526744A (ja)	2022-08-11	2025-08-15	ブリストル－マイヤーズスクイブカンパニー	Ｋｒａｓ阻害剤
JP2025527530A (ja)	2022-08-16	2025-08-22	ブリストル－マイヤーズスクイブカンパニー	Ｋｒａｓ阻害剤
CN120152721A (zh)	2022-09-01	2025-06-13	齐卡尼治疗股份有限公司	使用13元大环内酯治疗家族性腺瘤性息肉病
EP4584276A1 (de)	2022-09-07	2025-07-16	Bristol-Myers Squibb Company	Kras-g12d-hemmer
US20260070945A1 (en)	2022-09-12	2026-03-12	Bristol-Myers Squibb Company	Macrocyclic immunomodulators
TW202421650A (zh)	2022-09-14	2024-06-01	美商安進公司	雙特異性分子穩定組成物
WO2024091918A2 (en)	2022-10-25	2024-05-02	Modernatx, Inc.	Methods of lipid nanoparticle production in cross-mixers
WO2024112734A1 (en)	2022-11-21	2024-05-30	Dianthus Therapeutics Opco, Inc.	Antibodies that bind to c1s and uses thereof
CN115737992B (zh) *	2022-11-24	2024-06-07	深圳市本尚医疗科技有限公司	无针注射器
EP4626863A1 (de)	2022-11-30	2025-10-08	The Trustees of The University of Pennsylvania	Inhibitoren des brisc-deubiquitinierenden enzyms
WO2024121380A1 (en)	2022-12-08	2024-06-13	Pierre Fabre Medicament	Vaccinal composition and adjuvant
GB202219154D0 (en)	2022-12-19	2023-02-01	Metacurum Biotech Ab	Antibodies and uses thereof
US11806334B1 (en)	2023-01-12	2023-11-07	Bioxcel Therapeutics, Inc.	Non-sedating dexmedetomidine treatment regimens
EP4658687A1 (de)	2023-01-31	2025-12-10	University of Rochester	Immuncheckpoint-blockadetherapie zur behandlung von staphylococcus-aureus-infektionen
EP4665756A1 (de)	2023-02-13	2025-12-24	Intervet International B.V.	Antikörper gegen hunde-il-4
JP2026508149A (ja)	2023-02-13	2026-03-10	インターベットインターナショナルベー．フェー．	イヌｉｌ－１３に対するイヌ抗体
KR20250167153A (ko)	2023-03-03	2025-11-28	셀덱스 쎄라퓨틱스, 인크.	항-줄기 세포 인자(scf) 및 항-흉선 기질 림포포이에틴(tslp) 항체, 및 이중특이적 구축물
KR20250157375A (ko)	2023-03-08	2025-11-04	암젠 인크	이중특이적 분자에 대한 제어된 빙핵 형성 동결건조 공정
JP2026510891A (ja)	2023-03-16	2026-04-10	インマージーンプライベートリミテッド	Ｉｌｔ７標的化抗体及びそれらの使用
CN121263432A (zh)	2023-04-12	2026-01-02	上海康抗生物技术有限公司	包含掩蔽型白介素12的多功能分子及使用方法
WO2024218322A1 (en)	2023-04-21	2024-10-24	Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh)	Ferroptosis inhibitors
EP4705319A1 (de)	2023-05-04	2026-03-11	Affinivax, Inc.	Rhizavidinvarianten
CN121194795A (zh)	2023-05-18	2025-12-23	安尼欣制药有限公司	膜联蛋白a5蛋白质与抗vegf药剂作为组合疗法用于治疗黄斑水肿或视网膜静脉阻塞
CN121241137A (zh)	2023-05-24	2025-12-30	南京金斯瑞生物科技有限公司	用于制备环状rna的载体和方法
CN121620357A (zh)	2023-06-01	2026-03-06	赛诺菲巴斯德有限公司	包含mRNA脂质纳米颗粒的热稳定组合物
EP4725969A1 (de)	2023-06-09	2026-04-15	Latticon (Suzhou) Biopharmaceuticals Co., Ltd.	Komplementäres bispezifisches anti-her2-antikörper-wirkstoff-konjugat, herstellungsverfahren dafür und verwendung davon
WO2024255753A1 (zh)	2023-06-12	2024-12-19	南京蓬勃生物科技有限公司	结合人ccr8的抗体及其用途
UY40797A (es)	2023-06-14	2024-12-31	Amgen Inc	Moléculas captadoras de enmascaramiento de células t
WO2024259373A1 (en)	2023-06-14	2024-12-19	Modernatx, Inc.	Compounds and compositions for delivery of therapeutic agents
IL324670A (en)	2023-06-30	2026-01-01	Bristol Myers Squibb Co	KRAS inhibitors
AU2024287547A1 (en)	2023-07-07	2026-01-22	Viridian Therapeutics, Inc.	Methods of treating chronic thyroid eye disease
WO2025046492A1 (en)	2023-08-31	2025-03-06	Revagenix, Inc.	Broad spectrum aminoglycosides and uses thereof
WO2025051975A1 (en)	2023-09-06	2025-03-13	Sanofi	Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof
TW202519262A (zh)	2023-09-06	2025-05-16	美商維里迪恩醫療股份有限公司	抗ｉｇｆ－１ｒ抗體之醫藥組合物
WO2025082594A1 (en)	2023-10-17	2025-04-24	BioNTech SE	Antigen binding proteins specifically binding to cd3 and their use in medicine
AU2024364781A1 (en)	2023-10-17	2025-04-24	BioNTech SE	Antigen binding proteins specifically binding to cd3 and their use in medicine
WO2025122619A1 (en)	2023-12-06	2025-06-12	Bristol-Myers Squibb Company	Kras g12c inhibitors
WO2025136985A1 (en)	2023-12-17	2025-06-26	Viridian Therapeutics, Inc.	Compositions, doses, and methods for treatment of thyroid eye disease
WO2025151502A1 (en)	2024-01-09	2025-07-17	Viridian Therapeutics, Inc.	Modified antibodies
WO2025151492A1 (en)	2024-01-09	2025-07-17	Viridian Therapeutics, Inc.	Compositions and methods for treatment of thyroid eye disease
WO2025151496A1 (en)	2024-01-09	2025-07-17	Viridian Therapeutics, Inc.	Compositions and methods for treatment of thyroid eye disease
WO2025157389A1 (en)	2024-01-22	2025-07-31	Iomx Therapeutics Ag	Combinations of halogenated heterocyclic kinase inhibitors and vegfr inhibitors
WO2025160127A1 (en)	2024-01-23	2025-07-31	Modernatx, Inc.	Ionizable lipids and compositions thereof for delivery of therapeutic agents
WO2025160381A1 (en)	2024-01-26	2025-07-31	Modernatx, Inc.	Methods of preparing lipid nanoparticles
WO2025166202A1 (en)	2024-01-31	2025-08-07	Modernatx, Inc.	Lipid nanoparticle compositions comprising sialic acid derivatives and the uses thereof
WO2025168716A1 (en)	2024-02-07	2025-08-14	Eyebiotech Limited	Compositions, doses, and methods for treatment of ocular diseases
US20250281608A1 (en)	2024-03-05	2025-09-11	Zenas Biopharma, Inc.	STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF
WO2025193574A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193583A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193573A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193571A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193903A1 (en)	2024-03-15	2025-09-18	Affinivax, Inc.	Pneumococcal polysaccharide compositions and uses thereof
EP4643861A1 (de)	2024-04-30	2025-11-05	iOmx Therapeutics AG	Halogenierter heteroarylkinasehemmer zur behandlung von weichgewebesarkom und gefässtumoren
WO2025229127A1 (en)	2024-04-30	2025-11-06	Iomx Therapeutics Ag	A halogenated-heteroaryl kinase inhibitor for treating soft tissue sarcoma and vascular tumors
WO2025242910A1 (en)	2024-05-23	2025-11-27	Egle Therapeutics	Il18r agonist antibodies and uses thereof
EP4653460A1 (de)	2024-05-23	2025-11-26	Egle Therapeutics	Il18r-agonist-antikörper und verwendungen davon
WO2025257588A1 (en)	2024-06-10	2025-12-18	Affimed Gmbh	Cd16a/tumor antigen polyspecific binder for use in the treatment of immune checkpoint inhibitor resistance
EP4670733A1 (de)	2024-06-27	2025-12-31	Sanofi	Verfahren zur herstellung von viralen proteinen und deren verwendungen
WO2026027944A1 (en)	2024-07-30	2026-02-05	Sairopa B.V.	Anti-sirp alpha antibody formulations and uses thereof
WO2026027730A1 (en)	2024-07-31	2026-02-05	Sanofi	Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof
WO2026039512A1 (en)	2024-08-14	2026-02-19	Bristol-Myers Squibb Company	Kras inhibitors
WO2026044176A1 (en)	2024-08-23	2026-02-26	University Of Massachusetts	Anti-etec adhesin protein antibodies and methods of use
WO2026052773A1 (en)	2024-09-06	2026-03-12	Sanofi	Modified influenza a hemagglutinin polypeptides and nucleic acids and uses thereof
WO2026064599A1 (en)	2024-09-19	2026-03-26	Zenas Biopharma, Inc.	Stable formulations for ctla4-ig fusion proteins and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2704543A (en) *		1955-03-22		Hypo jet injector
US2101140A (en) *	1935-03-23	1937-12-07	Raymond W Hege	Automatic injecting syringe device
US2380534A (en) *	1941-04-26	1945-07-31	Marshall L Lockhart	Hypodermic injector
US2605763A (en) *	1948-01-31	1952-08-05	Becton Dickinson Co	Injection device
US2547099A (en) *	1948-03-11	1951-04-03	Becton Dickinson Co	Injection device and ampoule
US2680439A (en) *	1948-09-08	1954-06-08	Arnold K Sutermeister	High-pressure injection device
US2670121A (en) *	1951-01-31	1954-02-23	Scherer Corp R P	Flexible follower for metal ampoules
US2816543A (en) *	1954-07-12	1957-12-17	Scherer Corp R P	Hypodermic injector
NL133848C (de) *	1960-08-15
US3292621A (en) *	1963-07-19	1966-12-20	Oscar H Banker	Jet type protable inoculator
US3292622A (en) *	1964-09-21	1966-12-20	Oscar H Banker	Power operated inoculator
US3424154A (en) *	1965-11-08	1969-01-28	Charles W Kinsley	Injection system
US3561443A (en) *	1968-09-06	1971-02-09	Oscar H Banker	Inoculator gun with delayed action
US3688765A (en) *	1969-10-03	1972-09-05	Jack S Gasaway	Hypodermic injection device
US3945379A (en) *	1974-08-08	1976-03-23	Smithkline Corporation	Injection device
JPS51130094A (en) *	1975-05-08	1976-11-12	Asahi Chemical Ind	Twoostage pressure injector
CA1178503A (en) *	1982-05-27	1984-11-27	Health-Mor Personal Care Corporation	Needleless hypodermic injector
HU186718B (en) *	1983-06-29	1985-09-30	Radelkis Electrokemiai	Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin
US4596556A (en) *	1985-03-25	1986-06-24	Bioject, Inc.	Hypodermic injection apparatus
US4680027A (en) *	1985-12-12	1987-07-14	Injet Medical Products, Inc.	Needleless hypodermic injection device
EP0250022A3 (de) *	1986-06-17	1988-06-22	SICIM SpA	Tragbarer hypodermatischer Injektor
US4722728A (en) *	1987-01-23	1988-02-02	Patents Unlimited, Ltd.	Needleless hypodermic injector
US4940460A (en) *	1987-06-19	1990-07-10	Bioject, Inc.	Patient-fillable and non-invasive hypodermic injection device assembly
US4941880A (en) *	1987-06-19	1990-07-17	Bioject, Inc.	Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) *	1987-06-19	1988-12-13	Bioject, Inc.	Non-invasive hypodermic injection device
DE3814023A1 (de) *	1987-07-13	1989-01-26	Medizin Labortechnik Veb K	Injektionsvorrichtung mit medikamentendepot
CA1310870C (en) *	1987-11-16	1992-12-01	Medhi-Tek International Limited	Apparatus for hypodermic injection of liquids
US5073165A (en) *	1988-02-05	1991-12-17	Marpam International, Inc.	Hypodermic jet injector and cartridge therefor
US4913699A (en) *	1988-03-14	1990-04-03	Parsons James S	Disposable needleless injection system
US5024656A (en) *	1988-08-30	1991-06-18	Injet Medical Products, Inc.	Gas-pressure-regulated needleless injection system
CA1325149C (en) *	1989-08-31	1993-12-14	Gavin Mcgregor	Variable intensity remote controlled needleless injector
US5064413A (en) *	1989-11-09	1991-11-12	Bioject, Inc.	Needleless hypodermic injection device
US5062830A (en) *	1990-04-04	1991-11-05	Derata Corporation	Dry disposable nozzle assembly for medical jet injector
US5383851A (en) *	1992-07-24	1995-01-24	Bioject Inc.	Needleless hypodermic injection device

1992
- 1992-07-24 US US07/920,106 patent/US5383851A/en not_active Expired - Lifetime
1993
- 1993-07-23 CA CA002140772A patent/CA2140772C/en not_active Expired - Lifetime
- 1993-07-23 AT AT93918344T patent/ATE187083T1/de not_active IP Right Cessation
- 1993-07-23 DE DE69327165T patent/DE69327165T2/de not_active Expired - Lifetime
- 1993-07-23 WO PCT/US1993/006940 patent/WO1994002188A1/en not_active Ceased
- 1993-07-23 JP JP50471494A patent/JP3633615B2/ja not_active Expired - Lifetime
- 1993-07-23 AU AU47827/93A patent/AU676490B2/en not_active Expired
- 1993-07-23 EP EP93918344A patent/EP0651663B1/de not_active Expired - Lifetime
- 1993-07-23 US US08/097,266 patent/US5399163A/en not_active Expired - Lifetime
1995
- 1995-03-21 US US08/407,867 patent/US5520639A/en not_active Expired - Lifetime
2003
- 2003-12-24 JP JP2003426219A patent/JP2004141667A/ja active Pending

Also Published As

Publication number	Publication date
EP0651663A4 (de)	1995-08-30
JP3633615B2 (ja)	2005-03-30
DE69327165T2 (de)	2000-08-24
CA2140772C (en)	2006-07-11
US5399163A (en)	1995-03-21
CA2140772A1 (en)	1994-02-03
EP0651663B1 (de)	1999-12-01
EP0651663A1 (de)	1995-05-10
US5520639A (en)	1996-05-28
US5383851A (en)	1995-01-24
AU676490B2 (en)	1997-03-13
AU4782793A (en)	1994-02-14
JPH07509161A (ja)	1995-10-12
DE69327165D1 (de)	2000-01-05
WO1994002188A1 (en)	1994-02-03
JP2004141667A (ja)	2004-05-20

Legal Events

Date	Code	Title	Description
2000-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE187083T1 (de)	1999-12-15	Verfahren für nadellose subkutaninjektionen
US4421508A (en)	1983-12-20	Vacuum-compression injector
US4403609A (en)	1983-09-13	Vacuum-compression injector
US5370630A (en)	1994-12-06	Device for injection of fluidic materials into body tissue
DK0821600T3 (da)	2004-04-13	Selvskyllende angiografisk injektor
EP0879609A3 (de)	1999-06-02	Zweistufiger Druckstrahlinjektor
WO1993003780A1 (en)	1993-03-04	Injection syringe
WO1994002188A9 (en)	1994-03-31	Needleless hypodermic injection methods and device
ATE235931T1 (de)	2003-04-15	Druckstrahlinjektor
GB0214452D0 (en)	2002-07-31	Medical needle assemblies
CA2148173A1 (en)	1996-01-16	Delivery Device for Injectable Materials
US3130723A (en)	1964-04-28	Multidose jet injector
ATE478604T1 (de)	2010-09-15	Angiographische injektoranordnung
EP1229950A4 (de)	2003-03-05	Interdermales injektionssystem zum injizieren von auf dna beruhenden injektionsstoffen in den menschen
DK0567483T3 (da)	1997-12-29	Subkutaninjektionssprøjte
AU2003209095A1 (en)	2003-09-04	Intradermal injector
EP0830868A3 (de)	1998-05-13	Vorgefüllte Spritze für medizinische Zwecke
SU1426464A3 (ru)	1988-09-23	Устройство дл впрыска топлива
CA2481434A1 (en)	2003-10-23	Needleless syringe for the subcutaneous injection of droplets of liquid substances
WO2001013975A3 (en)	2001-09-07	Dna-based intramuscular injection system for humans
EP0316428A4 (de)	1989-10-16	Verteiler einer hypodermischen flüssigkeit.
DE3875935D1 (de)	1992-12-17	Kraftstoffeinspritzpumpe.
CN86206138U (zh)	1987-05-27	无针注射器
US3955490A (en)	1976-05-11	Injection system for meat products
SU1271524A1 (ru)	1986-11-23	Безыгольный инъектор